<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2605222076
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2022
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        DIBASA
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        CHOLECALCIFEROL
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        10000
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        IU/ml
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Oral drops, solution
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bottle
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c don't freeze
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        18.45
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="ABIOGEN PHARMA S.p.A. " />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            ABIOGEN PHARMA S.p.A. 
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 612]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Abdulrehman Algosaibi G.T.C.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            ABIOGEN PHARMA S.p.A. 
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        A11CC05
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><em>Dibasa contains cholecalciferol, which is better known as vitamin D3. Dibasa is indicated for the prevention and treatment of Vitamin D deficiency.</em></p><p><em>&nbsp;</em></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><em>Do not take Dibasa</em></p><p><em>- If you are allergic to cholecalciferol (vitamin D3) or any of the other ingredients of this medicine (listed in section 6).</em></p><p><em>- If you have high calcium levels in blood (hypercalcaemia) or in urine (hypercalciuria).</em></p><p><em>- If you have kidney stones (nephrolithiasis) or calcium deposits in the kidneys (nephrocalcinosis).</em></p><p><em>- If you have a kidney disease (renal insufficiency) (see section &ldquo;Warnings and precautions&rdquo;).</em></p><p><em>&nbsp;</em></p><p><em>Warnings and precautions</em></p><p><em>Talk to your doctor or pharmacist before taking Dibasa. The doctor might recommend taking Dibasa as prevention</em></p><p><em>against Vitamin D deficiency:</em></p><p><em>- for neonates (especially preterm babies) and infants;</em></p><p><em>- during the last trimester of pregnancy;</em></p><p><em>- for breastfeeding women, late in winter and in spring;</em></p><p><em>- for the elderly;</em></p><p><em>- in case of inadequate exposure to sunlight, particularly in the child and the adolescent;</em></p><p><em>- in case of an unbalanced diet (e.g., poor in calcium, vegetarian diet);</em></p><p><em>- in case of intense skin colouration;</em></p><p><em>- in case of extensive skin diseases, infectious diseases (e.g., tuberculosis, leprosy), digestive diseases or liver</em></p><p><em>diseases (hepatic insufficiency);</em></p><p><em>- in patients under treatment with antiepileptic medicines or under long-term therapy with certain antiinflammatory</em></p><p><em>agents.</em></p><p><em>The doctor might prescribe regular tests to check the levels of vitamin D or calcium in blood and urine in the following cases:</em></p><p><em>- if you need to take Dibasa for a prolonged period and at high doses;</em></p><p><em>- if you are elderly and already under treatment with medicines for certain heart diseases (cardiac glycosides) or with medicines that reduce blood pressure by increasing the production of urine (diuretics);</em></p><p><em>- if you have sarcoidosis, an inflammatory disease that can involve the entire body and lead to the formation of nodules. If your levels of vitamin D or calcium are high, your doctor will reduce the dose or interrupt treatment with Dibasa.</em></p><p><em>Generally, you should not take Dibasa if you have scarce kidney function (see section &ldquo;Do not take Dibasa&rdquo;); but if the doctor deems that treatment with Dibasa is absolutely necessary, you will need to perform regular tests to check blood levels of calcium and phosphate. If your calcium and phosphate levels are high, your doctor will reduce the dose or interrupt treatment with Dibasa.</em></p><p><em>Inform the doctor in the following cases because it might be necessary to increase the doses, compared to the ones indicated in section 3 &ldquo;How to take Dibasa&rdquo;:</em></p><p><em>- if you are taking medicines that are used to treat seizures (anticonvulsivants or barbiturates) (see section &ldquo;Other medicines and Dibasa&rdquo;);</em></p><p><em>- if you are taking cortisone, medicines that are used to treat inflammation (see section &ldquo;Other medicines and Dibasa&rdquo;);</em></p><p><em>- if you are taking medicines that are used to reduce the presence of fatty acids in the blood, such as cholestipol, cholestyramine and orlistat (see section &ldquo;Other medicines and Dibasa&rdquo;);</em></p><p><em>- if you are taking antacids that contain aluminium, medicines that are used to treat the excessive presence of acid in the stomach, which can even enter the oesophagus (see section &ldquo;Other medicines and</em></p><p><em>Dibasa&rdquo;);</em></p><p><em>- if you are obese;</em></p><p><em>- if you have digestive diseases (intestinal malabsorption, mucoviscidosis or cystic fibrosis);</em></p><p><em>- if you have a liver disease (hepatic insufficiency).</em></p><p><em>&nbsp;</em></p><p><em>Other medicines and Dibasa</em></p><p><em>Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.</em></p><p><em>Particularly, tell your doctor if you are taking the following medicines because they might reduce the effect of Dibasa:</em></p><p><em>- medicines that are used to treat seizures (anticonvulsivants or barbiturates);</em></p><p><em>- medicines that are used to reduce the presence of fatty acids in the blood, such as cholestipol, cholestyramine and orlistat;</em></p><p><em>- if you are taking antacids that contain aluminium, medicines that are used to treat the excessive presence of acid in the stomach, which can even enter the oesophagus;</em></p><p><em>- cortisone, medicines that are used to treat inflammation.</em></p><p><em>Moreover, if you are taking the following medicines, tell your doctor, who will monitor your condition and carefully evaluate whether you need to perform additional tests:</em></p><p><em>- thiazide diuretics, medicines that are used to treat high blood pressure by increasing the production of urine;</em></p><p><em>- digitalis medicine that is used to treat certain heart</em></p><p><em>diseases;</em></p><p><em>- preparations that contain magnesium;</em></p><p><em>- warfarin, medicine that is used to make blood more fluid.</em></p><p><em>&nbsp;</em></p><p><em>Dibasa with food, drink and alcohol</em></p><p><em>Tell your doctor if you are taking other products that already contain vitamin D, foods fortified with vitamin D or if you use milk enriched with vitamin D so that he might consider the total dose of vitamin D you are taking to avoid an excessive dose (see section &ldquo;Warnings and precautions&rdquo;).</em></p><p><em>The intake of high amounts of alcohol for a very long time (chronic alcoholism) reduces vitamin D reserves in the liver.</em></p><p><em>&nbsp;</em></p><p><em>Pregnancy and breastfeeding</em></p><p><em>If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.</em></p><p><em>&nbsp;</em></p><p><em>Pregnancy</em></p><p><em>During the first 6 months of pregnancy, the doctor will prescribe this medicine only if he deems it strictly necessary, due to the risk of harmful effects for the foetus. (See Section 3 &ldquo;If you take more Dibasa than you should&rdquo;)</em></p><p><em>&nbsp;</em></p><p><em>Breastfeeding</em></p><p><em>The doctor will prescribe this medicine during breastfeeding, when necessary. This does not substitute the administration of vitamin D to the neonate.</em></p><p><em>&nbsp;</em></p><p><em>Driving and using machines</em></p><p><em>It is unlikely that Dibasa will have any effects on the ability to drive vehicles.</em></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><em>Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.</em></p><p><em>The doses and duration of treatment will be assessed by the doctor based on your health condition. Do not exceed the doses indicated by the doctor.</em></p><p><em>The doses must be taken orally. You are recommended to take Dibasa with meals.</em></p><p><em>Dibasa 10,000 I.U./mL oral drops, solution The daily doses indicated below can even be taken once a week by multiplying the indicated daily dose by seven.</em></p><p><em>Neonates, children and adolescents (&lt;18 years)</em></p><p><em>Prevention: the recommended dose is 2-4 drops a day (equal to 500-1,000 I.U. of vitamin D3).</em></p><p><em>Treatment: the recommended dose is 8-16 drops a day (equal to 2,000-4,000 I.U. of vitamin D3) for 4-5 months.</em></p><p><em>&nbsp;</em></p><p><em>Pregnant women</em></p><p><em>The recommended dose is 2-3 drops a day (equal to 500-750 I.U. of vitamin D3) during the last trimester.</em></p><p><em>&nbsp;</em></p><p><em>Adults and the elderly</em></p><p><em>Prevention: the recommended dose is 3-4 drops a day (equal to 750-1,000 I.U. of vitamin D3). In case of a high risk of deficiency, the doctor will assess whether you need to increase the dose to 8 drops a day (equal to 2,000 I.U. of vitamin D3).</em></p><p><em>Treatment: the recommended dose is 20-30 drops a day (equal to 5,000-7,500 I.U. of vitamin D3) for 2 months, followed by the maintenance therapy, which will be assessed by your doctor based on your health condition.</em></p><p><em>&nbsp;</em></p><p><em>Instructions for use</em></p><p><em>The package contains 1 bottle and 1 dropper. The bottle</em></p><p><em>has a child-proof cap. The dropper has a cap. Follow the</em></p><p><em>instructions for use given below:</em></p><p><em>a. open the bottle by removing the cap as described below: press while unscrewing (see Figure 1);</em></p><p><em>b. unscrew the plastic cap that covers the tip of the dropper (see Figure 2);</em></p><p><em>c. insert the dropper into the bottle to collect the content; dose the number of drops prescribed by the doctor onto a teaspoon and take them;</em></p><p><em>d. close the bottle (see Figure 3); screw the cap on the tip of the dropper once again;</em></p><p><em>e. place the bottle and the dropper in the package once again.</em></p><p><img alt="" width="623" height="343" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAm8AAAFXCAYAAAD096nVAAAAAXNSR0IArs4c6QAAAARnQU1BAACxjwv8YQUAAAAJcEhZcwAADsMAAA7DAcdvqGQAAJ4hSURBVHhe7Z0H+BxV9f7/KEUQUDoqgiJVepEepATpHQKE3rs0kSolhB4gQEJIKCG0AIEklCQkQAKht4SOIkgvIvzoYEHvfz8334PXy2yZ3Z35zu6+7/PcZ3dnZmfuzJx77nvPPefc/+cEQRAEQRCEloHImyAIgiAIQgtB5E0QBEEQBKGFIPImCIIgCILQQhB5EwRBEARBaCGIvAmCIAiCILQQRN4EQRAEQRBaCCJvgiAIgiAILQSRN0EQBEEQhBaCyJsgCIIgCEILQeRNEARBEAShhSDyJgiCIAiC0EIQeRMEQRAEQWghiLwJgiAIgiC0ENqCvP2///f/VFRUVFRUVFS6teSFtiFvgpAG//nPf9ykSZPcCSec4IYMGeI+/PDDrj2tA8m9UFRINoVOhMhbSkhRCGnw6quvujPPPNMtvfTSbp111nH33Xef+9e//tW1t3UguReKCsmm0IkQeUsJKQqhGr788ks3efIDrk+fPm6LLbZwiyyyiJebNdZYw/31r3/tOqq1ILkXigrJptCJEHlLCSkKoRzeeecdd9ttt3nStummm7t5553XzTDDDG722Wd3P/rRj9whhxzi/v73v3cd3VqQ3AtFhWRT6ESIvKWEFIVg+Prrr93777/vHn30UTd8+HB3xBFHuNVWW83NM8887oc//KH7yU9+4n7xi1+4Oeec0y233HLe360Vp0yB5F4oKiSbQidC5C0lpCg6DwQcfP755+5vf/ube/vtt90bb7zhpk6d6kaOHOlOPfVUt95667lZZ53Vff/73/cWNkjbT3/6U7fwwgu7n//8534f/m7jx4/352pFSO6FokKyKXQiRN5SQoqifQCR+ve//+3+8Y9/uK+++sr7qn3yySfugw8+8ETtzTffdC+88IKbOHGiu+yyy9xxxx3n9t57b7fzzju7jTfe2C2xxBLeyvbjH//4G8L2s5/9zBM2iBuFbT/4wQ9c79693fPPP9915daD5L51gYxj8f344499Qd753aoDiRiSTaETIfKWElIU7QGmPN977z0f/XnFFVe4888/3/Xt29ftsccebq211vLBBauvvrpbZZVV3PLLL++JGsTMSBqf+LTNP//8bqGFFvLToxQjbWZ14zjK8ccf74lhq0Jy35p46KFH3NChV7k+fU51++yzj9t9993d7373O3fuuee6m266qaUHFAbJptCJEHlLCSmK9gBWh0ceecRHgy622GJu0UUX9VGh8803n5/+nGWWWfwnU54EHMwxxxxu7rnn9tOiCyywgFtwwQU9OYsJW1iMvEH66Cxb2dIhuW8tPPHEE95SvOaaa3n5W3HFFby1GHlnmp/UNcj9Jpts4k477TT32muvdf2z9SDZFDoRIm8pIUXRPrj//vvdCius4GaaaSY/tYkljSlQOrtyBVJWibBZ4RiOhwwSxHDDDTd0XbU1IblvDeCbee2117oNN9zQy+EWW2zuDjvsMDdw4EB31113eZm/5ZZb3DnnnOMOPfRQt+6665UGGAu4nXbayU2ceK/75z+Vg1AQWgEibykhRdE+eP31191RRx3lp0GxqGF5q4WY1VI4D9OpWOx23XVX99RTT3VdtTUhuS8+SENz+eWXe6vw4osv7s4++2z38ssvd+1NxoMPPuwOOuggN//887mVV17V3X77mK49rQPJptCJEHlLCSmK9gFO21ghIFmk84C8JRGxegrkjU6U6ddjjz3WffTRR11XbU1I7ouNf/7zn16WsSRTbrzxRu/XWQtYru2CCy7w8t+zZ09vnSPIoVUg2RQ6ESJvKSFF0V548MEHveUNv7Zmkzd8477zne/4KapWh+S+2CDw5le/+pUPsCE6mojSNPjiiy/8dCuBOfjEkQqnVSDZFDoRIm8pIUXRXiAVyFJLLeXJm/m0NasQiTrjjDO6Sy+9tOtqrQvJfbFx4IEHer/Nfv36dW1JD9LlELxAW8BPrlUg2RQ6ESJvKSFF0V7A723rrbf2Pm9Y4JJIWD0FIsg5iegjmW+rQ3JfXIwZM8bLWa9evdy7777btbU+8P8ddtjBLbnkku7uu+9uielTyabQiRB5SwkpivYCCXn/8Ic/+M6PyNBmBCxwDguC2GyzzdxDDz3UdbXWheS+mGC6c7fddvPW41tvvbVra2MYNWqUT51DQur/+7//69paXEg2hU6EyFtKSFG0Fz799FOfRuGXv/ylD1poFnkjvxvk7YAD9ncvvvhi19VaF5L74oG8gY899piX3f32269hq5vh1Vdf9cl8WY/3oYceLnx+Qsmm0IkQeUsJKYr2An4+RObRUeEz1CzyRr44yNtRRx1d6gxbNwGqQXJfPBCUcPrpp7u55prLDRs2rGtrc3DTTTf6/G/9+1/sl40rMiSbQidC5C0lpCjaC6RTuOeee9xKK63kV1NoRsQp5yBYgU71hBP+4N55572uq7UuJPfFA+lniAxlKTdWVGgmnnzySX/eXXbZxS8jV2RINoVOhMhbSkhRtBdwyCbNwqqrrupmm222plne8J9jxYaLLrrIZ71vdUjui4eXXnrJ+6YdeeSRTc8j+NZbb/mpU3xB//SnP3VtLSYkm+0HpuprL11/6jCIvKWEFEX7gXQh22+/vZtnnnl8Yt0kQpamEGmK5Y0F7XH+bqWEp+UguS8WWMbq1ltv9/5urKrQbHz22WeuT58+Xo6bbdVrNiSbrQum/hl4vP/+++7tt9/20f/I25133uXGjLnTjR07vmyx/ZMnTy4NZP7kfT7/9re/FX6av1kQeUsJKYr2A+Rtm2228dOczUgXAgHE323NNdd048eP77pKa0NyXyx8/PEn7uSTT/UW47Fjm7+kFZ3qgAEDfKLpSZMmdW0tJiSbxQcDWAJhxo4d6y655BLXt29fH+XP8oTkKMTK27t3b5+m5te//nVpULKUW3TRxdxiiy1Rtiy66OJuiSWWdKuttrrbaqutfNT1vvvu6y3RDDz69+/v7rjjDvfGG2901aK9IPKWElIU7QXM7qyygH8PPm9JZCxtsTQh66yzjh8VtgMk98UCVgryurEA/eOPP961tXnAF/T666/307K33XabbydFhWSzWGCNXYgay6xdeeWV7rjjjvOkirRJSy+9tB8QUFiW8Oc///k3ehNZY01eZi5WX311t+mmm7qNNtoosWy88cb+c801e3g3FQpT/JyTc5sOxjK9xRZbuCOOOMINHjzYPfLII97K1w4QeUsJKYr2AiNCkpGuuOKK7vvf/35TAhZQHCgQlAvKoh0guS8WXn31L95Csd1227k///nPXVubB8gaVguisG+44YZCT/1LNouBv/71r95Ke+6553orGjp1hhlm8O+HSH7IGaSMWY5DDjnEHX/88e6ss87yFjKscUz/Dx061EdOkxvzlVde8f6WSQV/zz/96SX36KNPuGuvvc7/97LLLnPnn3++XyUEix5tY6WVVi7p4wX9MoXTTTedW2uttfw+BiStbpETeUsJKYr2AovTT5gwwa8L2ayABYgbed623HJLN2XKlK4rtTYk98UCHdtqq63mfTX53mz861//9FYTXABIpSPLm1AOJDonOvl3v/udJ2xzzz23D9bC6gVZO/jggz05Y8oUfYhVjuTP+FVmBYLEXnvtNffggw+7ESNucccc83vvxoJ+xrcZCx/WwDvvvDPTemQJkbeUkKJoL2DiHzlylFthhRX8mo6Nkjf+T443HL3pWBkltgMk98XCyy+/7DtG/HzopJoN8h9ecMEF3opMIuAiQ7LZfSDAAN81rGpY15i52HbbbT1Zw5cYYoSOZRq+uwYAWI3x4YQw4oN86KGH+mCymWee2S8Dx3RqKxI4kbeUkKJoL3zxxZfummuuc8sss6z74Q9/2BTyhq8FljdyZNHJtgMk98UCcoXljekpLBnNBp1Z375nuAUXXKjwK4RINrsHb7/9Tom4neL1JkRojz328Eu0IY9FjfiEyGEpxOJGcASEEysc060ff/xx11GtAZG3lJCiaC9A3oYNu7bp5I2p0z333NP95S9/6bpSa0NyXywgV5A3nLGz8Hn74IMP3RFHHOXmmWde9+yzz3ZtLSYkm/kDd5Nhw652iyyyqNd7+LlB2orsGxkCKyDuBmeeeabX+9wDyyS2wlq+BpG3lJCiKB4Y5WG+J7Eo5vk0gLxdfXXzLG9ET+FTwXTTQQcd5OuVBv/85z8LOWqV3BcLRJsyLb/BBht4f6NmA7klfQPTSziHFxmSzfzBqhv77ruPm2WWWXzwQav6jZFj7ve//72bY445/Co7ZB5oFYi8pYQURfGAP8PTTz/tHaxZ65H8VPg21OIL1GzLG2HunIewdXyGPvzww64rlQej2KlTp7prrrnGR/gRtVU0SO6LBRyyzzvvPB9oM3r06K6tzQPy2LNnT3fAAQcUPrWCZDN/PPfcC26rrbb206U4/reyby99B4MUCNygQYO8v2crQOQtJaQoigkID8TnhBNOcL/5zW988lJ8MPBlIPT89ttvd88//7zviGLT/siRo91yyy3flIAFyBt+FOQzuummmxKnEfCtwJl3zJgxPrwdh1/84/bbbz/fEX/yySddRxYHkvtigWkf1uTF0nvOOef4AUAzgU8QS7yR7LToVhXJZv6YMuVpt912O7jpp5/e6zxcRO69996Wy6HGwJ9o6mWWWcbNOeecPh9cFgFAWUDkLSWkKIoNLBJXX321z+dD6g+UC/nbCFsnMu/kk092l156qe/4mA7Cd4jjiTZl5NVM8nbttdf6JVvefPNNTxy5JnmMyG1EXeh4kSeiUyGaWAuLOuqT3BcPTJ3ibL3zzjt7GWsmsGITMU3HltYVIW9INvPH1KnPlMhbL68z0XvoPNKEHHvssT4xOdOqRV6mCvcUBvwkoiZfIrMl9BcMorHEtQJE3lJCiqL4oGGS5JFRFKQNxcKoivxDLIGFnwad3o477uj9Nej8llpqKR8hGpOxtAXyxrWWWGIJbwXE8nfYYYe5rbfe2vtUoCQgk0w3cBwrO+Dsy5p8RYbkvnj44osvvN/bKqus4rPZNwtYhk888UQ/lZTF6g3NhmQzf0DeNtpoE69fTz+9rx+MkhMQHYvcEMlJuhAilRlQo5OZhejOdCFYpyGU77zzjk88vdNOO/nUJtSZgQq+ykwBFz262iDylhJSFK0BlATTj8OHD3frr7++TxpJIzUCx5SQLaMSLtHSaGF5FixpKDIUG8qB66AcqAPkjQJRxJ+IRZjphIsOyX3xwJQPxB8Zvuaaq7u2Ng7yuhEIQYZ6LMdFh2Qzfzz11LMlvbqBn2G4++67fIALaUIgP0xBQoTmm29evx9ZYiALYWI6ngAbLHNMxzdzpgELMeSMczIYJvqVpMB33XWXd2FhxsMG0T/96QJ+UM/g+eijj/Ypd+gTmAEpeoCOQeQtJaQoWgs0ZAgSfmUoEhtlQa7o9CBazSRwnAfrG4QNZcD1UGRmlieZJaQNJca0V6tAcl88YE1gdRDk7qSTTi7J+j+69jSGESNGeDklCo8Eq0WHZDN/GHkjye19993XtXValPKECePd2Wef47baalsvm7wflqZCJxLIxUoHe+21l1+RAQsv6TqYobjooov8MldXXHGF/yxX2D9kyBAfmEZQGP/lE/9MltyCKOI/zNq/uM8wC8Kg+nvf+56vC1O9PXtuWDruD36Kl2AL6oGeZhZG5O3bEHkTug1YEPBtW3vttR3TppApiBY+bo36ucWF86KoyPeGlQ+lwTaceokobcXEvZL7YoL0OCzSveWW27hnn32ha2v9wHpBJ8rU11VXXdX0QIgsINnMHyF5Y23oODDrq6/+7l588U8+KOvcc89xhx9+uNt1113duuuu6wcGDJgZQEOqbD1pdCbf2V+tcDz/p9h/7Df7mOWAjDH7wcyLuciceuqp3s9typSn3McfTwsMQ+YhfehqfN5E3r4NkTehW0FHRFAACxOvvPLK3jJmjb1ZBA6ShmJCEeFXR7oFFANm+1ZebUFyX0zgHoA8Y1247rrru7bWD6azsIqQALhVEkxLNvNHSN5YjB6fNoKyHnjgAZ87LQm4hzz33HPu5ptvdv369fOWsmOOOcYdeeSRPicmBAtrGf5ytRR81hgQ//a3v/V+xRDE4447zhM0zn322Wf7BeiJ7C+XfJftrLnKtbHIkdtQ5O3bEHkTCgPy+dBBMfKDwDHVmUTGai2QNs7DNCyjPqxuyy23nB/tPfzwwy3h11YJkvvigmlO/IyYLmo0MpRIO6aaevTokZjmpoiQbOaPeNoU/0tSNZFnE982S8tUzacN0vfpp5/6fJhvvPFG6sJggwAbzkFgRC0yiysAQQuQOojbKaec4v3yIG+QQZG3b0PkTcgdNGYaNg39qaee8lGoEydO9H4SNFjIFuZyCtaytBY4jocATnPQne8bqxsBCexjmhbHb0aF+GowMn3mmWf8NG4rTEkZJPfFBZ3W5ptv7tZZZx3fITWCW265xafNIeVDq0CymT9C8kYKJPQspAjic8YZZ7gDDzzQp0qylEwhwYLo5RF1yjWoE9ckeA0fY0glZJPBO9kIIJosL4d/Jzpc06bJEHkTcgOKgkaJzwVJTDHHY13D140gAogWBAvlQ6oFpjjZhsUsiaQlFfNt43yQNvw5aPw4vW6zzTbeFwnnXK47xxxz+msT4cQUFw61WExwlkW5FB2S++IBGbepKogbcnjdddd17a0PdLzIKfJJMATTXEUfZEg280cSeTMwMGUQwSAZ/0kSkZPfkqACfjNAeOSRR/y0PNOWWN/qBQTNCkSNNsH1aRdETUPO+vfv7+uADyd1sDyff/zjH/31mebFak37EXlLhsibkDkY1T366KPe9wFrBESJfGrkVZt11lm9JYxwcCKd8Imgs6MhDx482E+jEswAqasWgcoUKVGrdHSQM86HVQ8zPiZ5FANh6kQzXXHFUHfiiSe7vffe218D8zy53jgHhA//DJRdHqPReiG5LwawIOO3SWfEdA++PvgMMVBgYIAFoV589tnnbp999vXthemjQw891Mssgx86XGS6iJBs5o9K5M0AkYIIMUBlOh4yhw8a06vjxt3pV7YZNuwaH0GKLsZ37eCDD3b777+/nxmBeBHgFRd0NvJ/0kkn+ch90pPQDvCjI7k0RJG0JUT0s2IN12TNUurAYATf43DATFoRLM0ib+Uh8iZkCpZn2WefffzSWBArSBJWNTo3lsjCsRaSRDZ6smsz4sInA9JEziGUyqabbuo7Qf5fjsBBuujgsNSRJBXlUCntB5FXH374fz4yEOXBdU477XS31lpr+2v96Efzewsd/iJ0zkWE5L77gHxipRg3bpzvsBiUMOW/5ZZb+g4PiwL5DFnnlH1MUdWDBx98yP3mNxt55238NOkE6cw23HBDn4UeMoclm8FJkSDZzB/lyFsln0vkGN/fDz74wOtg1kd96KGHPakbOXKkJ3GkAGFKk5U9kPekAilDDpF5rGgkA8YlhSUQmRJlEA0B4xoQM66ZRC4NIm/VIfImZAJzlqWD4f1gOcNigDIg8zzKohagXOi0GMkxHQr541wQNkgcFjZ85Ej9seyyy7q+ffvWvZTK559/6R577HGvdHr12t7NMMMM3jJI5OArr7zSdVRxILnvHtDpYDXYeedd/PJDRNjRWTEtxJQP1g2mi5h6wtqMvxqRzfXgwgsv8iuNkPiX63JefIVIdkp6BVI9kOAUK3OR1n+UbOaPmLzZrAEDVCzDyGyj0+3l/m/XahZE3qpD5E1oOmjgZNBm+pEpz0022cSb1elw6gW+cqyBih8c05v4wWFto3HznYXvsUrUa+GIgTUQqxsBDljisBQWjcBJ7rsHkyc/6DbeeBO36aabu5tvHullE0KVBOQeNwEcsevBUUcd6RZaaEFvpY5B5npkEuJI3iymVYsyjSrZzB8xeTNgIcZyxmoGzHQw0/Dqq3/xpO6jjz6uaAFrJrgOMvv++39zb775lq8X8sqgI/axE3mrDpE3oenAx4wGh0/btttuW7clLAbEDOdafOSwwGEZw/qGTwYO4s0e/UFCsW6wCgTXY0WIIqUXkdznD2Rw6623cbvttrv346wGfCzpNPHzSQvcCC644CLXp89pFSNWkUmmqxgkHXHE4U0bwDQCyWb+KDdtil6EHLEEFn5ryOOQIYNLg91hbty4Cd7/jYE1JIrpd1KE4LKClbceSx3XQiYZ0EAQIWl8IsNMyY4YMdJfGx+5iy++2AeJxTJLHcjFKfJWHiJvQtPBIsJYG3gvF154YdfW5oGIO/zgyODNGnh0clkC5/Dpp5/eT5HRGec1Uq0GyX2+4L0z9UTniD9QLaATxIqAHyf+nExfIUPk2/rHP5KXuWLaFQsJLgDDh9/oLRXVZI79+CatvfavSwOZBxvOLdcoJJv5o1rAAjKBuwpEjahPfNQgUtddd4MPTiARNANU3EbwY2NwgpUOQoeORS6xnCUVZJtBOz5tpH9CfkeNGuVdTsgqcNppp3k/0Ouvv9HddNPN3qcOMgepg+TFdaXNEOgj8lYeIm9C00GjZL083gt+boz4qiWGTAMa+rPPPusVQB6O2vjpkeQXKx8dJB1yESC5zxd0fgwcCLihY6lkDUsCHSd5togSHT9+grv77nu8XyiO4ETxYYGgQ4XgIXP4ubEGcK24664JbqWVVnZnnXVut6e6kWzmj2rkLQQ+yVi7GEQwhcn0JYTu8ccf96SNIAPkEFlFFlnGkMEEBI/peaJPSV1j33ExITsAxI+oUnQzvsoEKjDgwR+UNVbfeeddT8w+//yzivWjHptttpmbffbZlaS3DETehKYDyxvr1zGtSfQnDtv4q0G4molmT5MmgSkFnMK5Fyx9jFDLLeuSNyT3+QMXgDXWWMP7czIFBZlDRugMawHTSXRE48ff7Vg668QTT/CWBYIeGOjQQULi0izbxrUhklhNCG4gVQPTTt0JyWb+SEPeKoFBCsSOgTFyyOAbaxrrpTI9TyEAh2LfuR6EC6sylj0GKljk0oLrsFQXC9zTxkj7BGEUefs2RN6EpoNRFtOmWKpIEcLoabbZZvNBBUxzElbeaNRT1mCagPxEJPZlpQdkjOWO8Lkrgk8RkNznCwYLWCdIRYO1DKsEpItgFqaJSEQKsYegId+VBhfsopPEr4jjKXR2ELFKna75L3311ZdeDrkmwUEQN3IlQgRJVVJrNHdWkGzmj2aRt7zAbAxWOAb7pHYi4IyZDdKLsEQWKaaYNt1tt91E3hIg8iY0HVjYsFJhccPkThLHrbfe2i91QhAD64vSIHFIpcGSOgRfCcvvlie+/vpfpY7uw9II8y8+TQjTA6R3INCCJbZIQUL+LlKeEHk6cOBATZt2KJBNstBD6JlWwgeIjofOhkHJVltt5bPCMzU6efL9vsOx3IUQs3pkG3LH/+nksIQwvQVRxNqB4zlkjbV6sQBi9cDCTXJUpsO6E5LN/FEveUMuGXSgt7GevfDCi+6tt972g4NG9DH/Re6xAjNlitUaGcWPjuUIseRhZWMghIsAfnFsAwxQSHgNeWN1HJG3b0PkTWg6UAKLLLKIJ2kWkUfjwxTOaIrEpeRP472R9sNyZdHxkfaAaSM6I0gdfhP4/UydOtVb9OgMUSoom6TCPhxnUQ5cG2VB4Tz4XhCVijMu14BUnndeP3fAAQeWOt5t3RprrOmjSqkX5nqWN4Jg8l8IHVPABGCIvHUmjLxtscUWvnM0MOjAIjd69KgSqRpRIviXljqivn5ZK5b+IU0Dco1f0Kmnnuq3M/0O+UoqZ555pv+kvRCRhy8Rn1h9aSMnnHBiSW77lwYa13qncOQTkofscw2Rt87E1KnPuvXW6+mnztGdtQKSh37G6oX8DBo0pCTLt/lzoMtJhYM+hXRZ5GhYSIbO9CrkzI7HlYDvtAv83/DpxM3gvPPO8zMaDD5If8NgGcKI7jZgfWZQxKCEWQ/IW1FXEomRp9yLvAlNh5E3kubScEPQSFl1ARKEjw/+Q4wUWTkBwgRBYnoSQsc+CBTLDJGlHosHyUixLpx44omJhdEaObU4Hp8JolIpnAfrGWlGII8QS6yDWAMhbFjZSAnCMTjI0lGGqSDIOSTy1tkw8sYqCmYhiEHH88c/vlSS+0l+6ofpINKEYGEg8zzyg/XWCF2lQscGOeMcOI8zoOH3hAl3uaeeeqbUlj7quuo00JGyrJvIW2cCy9u6667vdS+BL7FrCvLLVD0lBnKL/EC8nnrqaS/nyBszJwxgWeGD2RLkCzlGhinIKYMLBrfoZwbhHI/+JLoUeWVan0Ez5A7yx1Q/VmuuiYXN6sRvrHQM1hn0sMINfQIJ2qlXK0DkLSWkKIqFkLwxxcPIDsLz5Zf/G3FKg8U3h9EZnRu+QxAtiBdkizVHIXFMvxIAwfJYRH3yWanYMUS8QtKWX355fw7OB3mDoEEIiWZCKeEkjtUE5QK5jKcbUDgELZAMGKUk8taZqIW8JYH/WceJhQxLXS2FzgxZ5L+1AAsIU08ib52JP/3pJder1w4+uAoZhfBDjgx8xz0FqxY+luWAnCJ/ECxmMUgEjdWNoBgsaljBwsI2zmnWOY6HCDJLgj5FX3K+ctO4uAXQrnA3YPqUQQvEb6211vJ6HCJXT/BDd0DkLSWkKIoFI28QJ0zvNN6xY8eVCNqoUqN+O7ERG8HDt4eRGcoAczqWO0ZuOIebXwSm/XIFIsYxLIhMJJStu0dnC0mkbha2TgeHcinnj4Sy41hGlyxBhHWQqSyRt84EMkLqA6ZN00xL5QXaDZYRpptE3joPEDL8L1dffXU33XTT+cEqll7kwgDBJz0N05dM4TNoJjkv5CovoOu5JtfGPQArNNZp9DN6H5cWyCcBb9ttt50fVLcKRN5SQoqiWAgtb0yRYr7HJ+KSSwa5448/wfs6MFrDRyccGVYC5yCZI6M0/kfhe7nCsVguzOpRK7jOe++96+uN79GAAZe42267w/tdsIYqGcFF3joXdDAEsOCzg4WiSKDjO/DAA/0UllKFdCbQeUzXM3uBsz/rQTOViSULvzYIHmSOQS2WLpvWZz8WL7azCsJDDz3iByjIO5Y0ZkjIHchAF+txDPSmRU0zIGZwzNT+tHNNOx8DaJaLs+lUrn3bbbf6QTrpRbC+EcBGNDcZCnBjYdqWQB2sgFyXEk8HFwkibykhRVEslPN5+/OfX/INGCsaTqs4yKJAGGkxYsTHjCnKPDoelBxKBrO/WfaoA/W5+OIB3hkci92UKU+VlN173tcOnzdNm3Y2sFwwtQ+BQ5bTDAyyBDKJNQU/ITrF7u7gJJvdC3QwVjfcTrDC/exnP3O7776711+QsnDalOlQ08noQHwqR4y45ZtgGfaNG3dnSZffWxrUTi7J/T1eZ2KFJliGgS4+nuybOPG+kt6c4GVw2LBrSzr+MnfjjeSBm+T/x3KD7MOHjcHPX//6Nzd58mTfF+ywww5+mpQIfwbK+Caz9CFpcJh1wceO+lMvrHaQVAKHmKotyrSqyFtKSFEUC+XImwHLGJGfmO9ZZojRGJm5IU6jRt1aatx3+CzdRIP279/fT1uiQOgsKTjSQvQYEUL2IGBYHfjOJ86xHIeCoXFzHRQT0U4429Lwceil8TMCZLTHfuqCYrn99jt8uLzhyy+/8H5EIm8CpAjZYjoHn5y+fc90b7zxdtfe7gGuBieddJL362TlB9pXd0OyWQygQ5ELovuxwqGXyb2JnGBxg3xhkWPAbIQf6xa+bmwnaS4BBPfd90BJl97rJk2aXNKb4330KG4pfELIbr99TIm83V/S95P9J1Y0rHboacghljvzoeOcpNq5/vrhbrfd9iz1E8v4NEzoVwLICB5beOGF3U9+8hMfsEBhG3Xnc/HFF/d+zBTuBX9kZkSwGlJX/O1qndFpNkTeUkKKolioRt5CMPpiChSzOb4NDz9MlNM9JcVwgx9tETlKpCeNE4IF0TKixygRgsYnZA8HXUgZ+ziW4zie0SO+QCQvJdUC2yFp1I3s4ZA/phLKkTKUDuSNUaHImwDolIh67tVrR9e7987efwiLRtKUUhago6UTxLeTHIpYAvH5TLMyQ5aQbBYD6NT111/fB1shJ1iNmY6EKDE1SXBXjx49fLAYFi30IoQOwoVfGmQL/0kGCKyxO+3zfR+MEBeOZYoTv2b+j0UMHYubDH5t+CKTSBpftllmmcVfGzK24oor+Wlelp2DYC644IKevHEc+yFxWOLCYtvQydwLGQN+8IMf+D4HXc0AHb2et64WeUsJKYpiIYm8Mb2EHxrWMj7TAidX/gfRg0xxHogXSsIKwQWMFlEioV9cox2qyJuQBGQS6y2pDDbaaCOfYgZ/MwYMDCjw62wGmeM6yCCdIYMT/IBIi8P1evbs6QMosF5zXFEg2ex+oHOZpWDqFGsVrh+k8bCUShApSNJMM83k5pxzTk/wmF5l6p20H0TikwQaP8ojjzzCLzIPyaPw3QrnZZBNDs/evXt7HzvIGGXllVf254VoQdawopHbk3RQDKaZVbnwwot97kKSXFNPiBn1omCRMyJnhTpagdwRSIZu5vwQOf7PeWiT5FSEwOY1qBJ5SwkpimIhibxhYcNSQGNiqhIzOmSMRlWP4zeKif/RYYUlrQ8Sx2Nix2fik08+TYy6EnkTKgH5weqGb46loKEjokPD6su0PdNEFHMCZ6Bh0/18UuhkOAYfIo5j+p//Yklmyp9OlA6VSDyWmmMNUywMDFKKBslm9wN9yJQmliysbuZmgmWNlCFMLzK9SQABsnvAAft7+SW/JlYwsgWQoomkv5At9DnLHkKM+B0X9lGYzuS/+KxxLtoD+pPE1Pit4bqCNY7IfZJZDxt2tZ9+xScPcob1zcibEbhqhf6GAqFDT0NGCdhgG6mhyCnKQKueviYNRN5SQoqiWChnecNJls6K0RY+F3ziPwSpQ5FAoGhclLQkrBo437///d8klRAwTPzPPfe894sbOfJWN2jQYK/MYkDeDj/8cJE3oSIYiCAryDPT9ljGmKKiMHVFh0ZCar5j9dh///291W6//fbzn3SwpKSh86Pt8D8sa1hC+B9WEHyYiM7Dolwpd1Z3Q7LZ/TDyBrmBRBEhjeyg90JA6BgEEGDANPyhhx7qBx6k8bCVQJj2NDcUiBffsQBT+E5wBNP2HM9Ag0E658C6xnbIGYEJ9Af4FvPJ4OSqq4b6QJvhw290xxxzTKmNLOstZ0bKsKxBPuOCtS0ubOd4+w8WP6ZTsfSxUgMkDkshJC4rS5zIW0pIURQL1Xze8KUgYAF/NRo1CgHrAiPAc845x517bj93++1j3ZNPTvGkDgtdPQ6oKC/C2994442S0nrCE7QzzzzL+78NGTLYL2V0zTXXlzraq32EFCHtRBPG4BwoIgUsCLUCGUHu6LzITI+1g46NqSX8LpleZbqJNVEZyGCZoGPBt5PCd8gfEc/IHP/DMocsNntgkwUkm90PBqkMkCFDDAAgWawjCnmB1EHmkMtpFt4xJXL1gF+Td+zYMX5Ai1sKBf9OCz4gwhQShoWY/zLYpRAowG+sxuh2tjEwx4cOGTbixuCDbbi3gM8//6ykl0e5Cy64sNQGDvcBCEx/QrywnDHNim9eWNiGZc0KxIzP+Fh+Q97YZySO7fj40aYgrc2GyFtKSFEUC7UGLDD6oQHRKbH+KEqECKhrr73ORy8Rns5vCj49OLzis0HHR0eIIiBQwQp5itjOMYz2sH5wDKlI7rxzfElp3OEDIYhcnTz5Pn/dZ555zrGcEWlDygECiS8HljfleRPSgEAGLAqAzg+Z5BMLCPJOR0dhmpSOkelTOjZ82wjYQfbobAnawdWgVSDZ7H4w4MVqNvPMM7uDDjrIz2yQogN9is8bATe4sGApRgYhW5AsZPPBBx9248ffVTr2Vj+4xrKGCwBkEOscU55miUOmOSfyDMlD/zMty7VYk/qxxx73pI6AMgge9SBV07RccE95/1DOwcCdlXUgWksuuYTvP7BC2zKH+LBtsskm3h+PARHWa6ZaGeTwm/xwHMfUL1Y2rNicA6s1068MvnkWyCY+eAyQmh3gI/KWElIUxQLLpNRC3sqBESNkCgsdIziW2ELJYIrHNwOHWxQIZI3RoxXM+XR4HIPSIpSdUR6dIlaQtL5BRFWhbLAIsqwWvhhaYUFIAyxrWG0B1gkGE7gOMHVF52UF+UTe6UwoWD6QZYIeGGxgmcNnqVUg2ex+QN4gaeRNg6jEwI0F30tSbDADwjJU6LqRI0eX9O1tpQHxHSW9erOfMoVcYUGzgYYV89FEXs2aZkDOb7319tI5r/HE7IwzTvckD3KHXqUt2DUJxoHs9erVy5Osww8/wud+gyBybkgepDLMDmCRrxb9iiEAssgxzOowmwPhZBqXPoE8cvjhMR2LBY7oVNoVmQ6aBZG3lJCiKBboZFhXFCfWeshbGqCgrDQDKDSUCIoJix0KBL8OnMQhb7K8CWnAlKiRN7O8QeLo6Ojc4kLHROQ0HSUdnpE3fC6zmObJCpLN7gfWrW233da/C+QwCRA3ZiqQN/Q2uo1BLuk+GETgEwxpwqUEwoVljcI25BnyBrligI3sMpuCZQ1CBTHkP0zFMjPC4BtLGYNv/N74P9dA5+LiAonCsrbYYkt4txnqT6nHr5P/0Cfwf3xDuQYDJgwLDPJ5Lljf0OkMkpqVGF7kLSWkKIoFRlaLLrqoN3mnJW/49FhuIRRJszPF06hpzCgoG7HZqI2pW0aR5DvCL4lGjkJBCfCbESHTByJvQq1IIm9YBhggiLwJWQIiRcBLJfIGaUFf40LCFL0BS/Add9zuLXK33DLKkzwKU/gU+040NIVjbrhhhPelY8CLuwBr7KIvIXbMfmA9w8IGYcMFIA4agOixHuvPf76wl/msALnE2s00LlOt+ANyn82AyFtKSFHkC6Y1IVUU+w4hgnihBCA6OJyyQHIa8gaxwuzNqgo0epQDIyVGTDYi5JNRFA0fUmX1oPDbRn4U+w8BDxRIIZ0mnSjKAf8NpgQgaYSvMzLETI8y43hLG8LoDeUHeaNuIm9CrRB5E7oL+K+R6uO73/2udzOpBHQ3es2sXLitQLZwWyFxOsQKAhYXLHDoy2eeebb0/UlvVTb/ZcskgN7lfNUsaMg/KXaY5t1vv31zcROgrfXp09edfvqZpe/Pd22tHyJvKSFFkQ/wM6DjweTNVCI+Z0wtQn4wvWMSx1nUnEMZ0UDA0gBrGKZ4roGfG75sXAvnWlIr9O3b1xMu9qOcsJRZ4Tc+FRwPGcPfA2dW8mHhA8c6e8OH31Q672h3662jfd3w4cC8z0iT0RhWOAipgdQPEyaM93m1CFhgsfq0vnNZQXJffIi8CXmDASyWpA033NBHWpI0F4tXWkC2bGCOzoOAkaImLOhH9jNwDvVmPeA89CcEGuCPhu5G/rMG66uSeQA/uWoEsxpE3lJCiiIbQGQYQUGEIED4IxANRDg3U6I0Mr6TwdsIG+HdKAwsb+TaIYdPUqOmoZplKwaWLhQDZJEOi5EdxAyyRX1sVEf2cBoche8cwwgRfzXIHOZ6Ipn4H9ux4v35zy+7N998q0QS/+oVD9eKAYkj0IGAB6JeWaie9QHnn/9HPqT9009leRNqg8ibkCeYcSAAgGS3vAPW4GU2pFVAn0AEK30H9Se5Lta8rME0LlZC2mUjqXjylHuRN+FbwBLF9CE5qsiOTYZtFjaefvrpfag1odyQNMuvwydkLUyUSG4htpNTBwIXj/yIrMM/gmggnFkhTGkA8cIcbz5rfMd/gxFgWvz97/8oNdxnSnUZ4i67bIjvLElayZTB2LHj3H777e9mm222EoFbsaRIpvjRaBEguS8+RN6EvIB7CSsYsAIC0ZTMguRBfNICgsZMB3o7Cehx/OZwu6HfIUUIg3B0flbAFYd+iFmkRvS7yFtKSFE0DhoM1irI1K677uoJG+QL0oIJmylDI2eW0RqShsWN4AQK6UEohGKzTAnHQO74D6Z7yBrEEEscPmVYtyB2TIPyncbDdChWshdeeNG9+uprvpFjgcNsT6NPS86+/vq/Zn/OYykZ6BSxzHG922+/o/Q52vXrd16JtF7uR6qQTaZvmQ7mnsgVRCBDkSC5Lz5E3oSsgU5EZpgdIREtA2dSY6QdEGcJrFn41JH/DYJ00kkn+RmTcmDql4ACCChrr0JIifTPItchpBDdvt5663n3nHoMAAaRt5SQoqgf+JhBllh1gOV4eJYUs7JhYYOIhaSN74RYQ+44htGR5c3BKgfRs0WDCcfmHDjNck4WK6bxQuIgcICRDh0afmnkxbryyqHu5ptHed80kuqSgZup0EcemZbcFEVF52c5seLCPuscp07F6faxElG7tysq6hY/jUq0FMoAJcI2SB1TqBA8LG5ES0FI7XmQI4jzFQmS++JD5E3IEliMWDUB/zZ0MXqZwCvTrd0NSBtEDNknRQgzOehV9G61OtIvYDlk4M+94ZZDsmGmN5uxyggkjbZIEm1SW9Fv0V4beXZ5yr3IW4cCaxSdBZnbV155Zd8wIGM0fogX1iYaGSZrRnR77bWXdyCl8J11FlmjkWOwvtnxRDexODHngLhB5mgYTJ+yjSVLIH8bbLCBDyjA2vfGG697EvnRRx97ZQSJwqSOrxvLVo0de6ebOHGSu+22MW7EiJu9T4flX0sqjKKY9sVnjSSRt90GWbvzm3xE+L4xAmQUx3Qr6UDYRlJHfCwgsTwLyCe+fbZYMs8B0tnIyKyZkNwXHyJvQlZAhtDfzAoQoYlPMgFbzcpZ1gjwvXv++RdLRPJst9VWW3qrFq41M8wwgw88S5MYF7nHuIBFEcsifQcBGfRh9YDpZfoGUpkQiIaex/gwzzzz+GXokpZIrBUibykhRZEOTCEShECgAaMNyBZLjhBJybI8EBRM7hQsUSgDiE5YyG5tWeKZhrROBwsZJnsUCpY4SA+NBCLGecl2TYOB8EHuIHLLLLO0n6odMOASvyTLc889W7ruO96czSiIwnfqTSCDXb9cgQhSOI4Iqf/7v4/8PUDYqCcRpvi0QQDJPE7WbYinJW2EvEFOMeuT+4ioWgguU8hrrbWWH+kSWt/dkNwXHyJvQrOB2wkBWuQom2WWWfyAmJUCsEh1FyBSyCozGrjBMAjeeONNSoP6RT2xZOpzlllm9gEUyHlaoMchXCx/NeOMM/o+i36GmZZKYKBNyhH6JZZYxGCAJQ99zhqqkDY+IYYYMND7jUw3i7ylhBRF7WBExJIkCCsWJRbHxvqFgEOMGjVHk96DdeWYSmWFBZaTYkrSgN8DJI4UIHRsEDkaDw0S/7iFFvqZj+wkA/ahhx7qG+g555zt86txLqxjkCdGXnFhO351dJAcS644pmJpsIxQUShYEpdbbjlvBWSkhWKhQGRp1HSYWOfCBswzw2GWNfaQNYiprTvZnZDcFx8ib0IzwSCUmQci/XnGOPXj/sEgO098+eVX7tVXX/eDfaJDkVWsVljYmGnBwkaxDATMZGy3XS+/zmkjfQz+yEy5MsiGtO63335+xQcDfRhthvZDX0EfwFQr7jroeOpBX8OMEOcwv23cgTBksF5q2F+lRZ5yL/LWYSAgYZVVVvFEhVES04bNAKM+OiqIzWyzze622mobd/PNt1SMEGJqlMaIL1r//hf4qM5NN53WyBgRUWj8EE0aGg0MxcA1GHklFRxbaYw0So7nv1jUIIg0WL5D3hi1HnnkkZ7cQSRJOEmHWs7fAYWDxQ4FhQKgXjR0pmK7C5L74kPkTWgWkI3TTjvN6zZ8wBjgZq1/cGFhFoPBrKVsIsjr/PMvKA2uD/ckkvqYiwxEDZ2LDiZwDb3NoHz99XuWBsWT3b//3bivGrMr+M/hqsPszhZbbOHdZJghOf300z2hI4UVszoU9DV1gJyFhC0sbOceGOAzQ1MvRN5SQoqiOkg+SKeBeZ0IymZlr8acPWbMWL/2JwEJ+DVAip58cmrXEbXjgw8+LHVcf/SWL0aTZ599tvd1wKH04IMPdjvvvLPbcccdKxYCC5iC5Xg6TSyLBB/QEWK9YzTGqg90hFjU0gIldtFFF3mlRRAG5nemX/Me+QLJffEh8iY0A8gGri2QNnQsgV3IShZAp+OThpwysIUw4vpiwQYQJsqcc05LEQVZozBYZjaHAiGCODG7gTUOGU4DSCMDaYwLzHCwFjArN0BWsfQx6GYWBcJl5Gxaneb0A3XqxT4b+DPTYvVKKiJv3QQpiurAnMxyUEwv8r0ZeOWVv/iRzqKLLuKJzNprr+07J0ZqzQTEk+lWiBMdGD525Qr7aXz4x6EAiHRqNqgPnSv+GyhTFBTKlMioRrOMp4HkvvgQeRMaARZ/3ExYvQZXFCz+DB6buUQfOgufNWZJiOZneUOIGgnZSRllxAYixPUhR/wOSVESMeJ4CBxuKxbkxf1wPX6jn7muLc0FUUPemQVhpQUG7wTHbb311r4+uNgwTYzFjcI1uT7XoD5GJCGRleqVVETeuglSFJVBQ5kyZaqf/29Gtu1pod+Puf33P8ibyueZZ25v9cKkngaEghNd2qpA0eBLR4QtU7wsAk2uumYq1kqQ3BcfIm9CIyDXJD7Epl/wMavkipIGEKmXX37FXXfdcO9fTDAW0fUQI4gQRI1pUKYbITZGiiA7TIlSYhIUFogU52KKE7mmz5gw4R53/fXDPQFlVoUZEoIQIGUEjlFwm8FfGheZkJhRD4ijua1QH65jdQlLXJdqReStmyBFURmk4Lj66mvdkUce5Uc1jYDREqZ0GhmO/jQypiMxbad1RMUCSH1I09Esa2DeYNRIMAMKFkdY/PEgyc22PiZBcl98iLwJ9QI/YqxOPMtll1029eC4HNDhuI5g2erVa4eSDl/WEyNmT0jFwXdIEwWyVi8pMqKHawlTnKSWWnPNHm6llVb2A16IHQQPiyLBDdMiUmfxUf0YBSBqZkmz+uCvhjWtXpJWrnAN7lsBCzlDiqIySJnBKAeiddxxx/kUH/UAHzH8uzgPz3y11Vbz6TTqTZuBEqGT6tWrl1+Kq57Fk4sALIgEM3AfKB9GhUyjZu0HJ7kvPkTehHrAeyc4CiLD9CVBXY0CmcNthj6AKUjIDxGbs802qycuzSZFnIdzQsIghZA0I2ZY9NCTNvVqU6FWrB7Nqku1AjHE/YUZJNxv6oXIW0pIUVQGvmI4+2NupqEQpYS1DF+KWn20iPAhbQcjIRof5u5m5BV655133SmnnOZHYgQBkGeHVCZ0cPittRLIOYQPIM8YRdW7d29vVcwKkvviQ+RNSAv8wPA7Y2YDq1UjFjf0O87+pFHad999vZ41IgVhCy1rSaSmGSUkYnFJOj7PYnWATEIymT6mr6sXIm8pIUVRGVi0IEaQLkY+FNJqkC4D0zm52eg0yoHoI0gJ/8NBn5FbI34BMd5++10fBUu0Ku8SXwemC7BesWICyqtVplUhnKzwQMoS7oX7gCRnAcl98SHyJqQFqTiI6iRyktRO9QACiLyQmJa0UPhzQQYhKea/VqszfzsWI488B54JZBafQlxg0rr/hMhT7kXeOgAEKUCICKXGZ4DRFgLLFB+/cRYlqocVFiBL5H+jI8ExlpQibEeZ4MzKQvJMwzYbf/7zS96aB8GkXjQmRkL4kOHQSidI3WhckFEIJVGfRQTTyyQLxi9wuumm8xY4nmezIbkvPkTehFoxLYDgZe8/C9Fi8EouzHqAawwzGJwLZ3+IINOC6FRKGCmaRG7auXDPTJPyXHgmfELcWHWn0WwBIm8pIUVRGSRXZMkn/BvMTI4AM+pgGhQBhtjhcI9lDVM9ZI7Og/w+/Af/BPKtoVwgJ42MTsqBKUbWvWNkaP4QKBojdBT87Zha7du3r8/ZhlWODo+ODUKXRb3qAUoAPxX8ArEokjiykTXzkiC5Lz5E3oRawXQdOdUgExtvvLFPPVQv8CdGxohOZUlCpgNZZYBpUwbuFK6DrqUPQNe2O5FbcMGf+vvlvukL6fOIsCUPKG0Sa2WjEHlLCSmKyojJWyzURuIQbGvM+EPQwCFPECkaNr5y+L1hyh87dqy36NGhMIXKsi2QOpz3GyFQWNXwz4NQUgcsg2HdKOyD0FEnlqzCyRR/DpQUnR5K77XXXvWj1s8++7zbCB0pWsj6Ta4k6gzhbGZqFMl98SHyJtQK5GONNdbwOo4lsCw3WqNgBoUISvQ1syoDBw70S0YxM4COh8TQN6Cj2oXEhQYKCpa2+eefz7v+8Juk8v369fPPvJmZAUTeUkKKojKqkbe4cAzCDmlC0PlNo7aGQDQQFjDWIKUQBs5KBmS+xtpEbiIsdJAnFAejQBQRxA6LVLXpTpQM56W+8VIm1IU6MHqCVKLobARJg4Uoca+rr76aD/vu3/8iN2nSfT5jOJY56pAnuHfWQYVs4gdHtFezlLLkvvgQeRNqwaeffu4uuKC/J1CbbbapDzLICuTpRD8zAMc/l+AIyAy6E53L7AukzlxsYh2cdzH/NAq/qU9crF/A2EBgHkEZTD3zHSMAZbPNtnB9+vT1foAM8LPIMSrylhJSFJWRlrxR4gZjBI7GQcO2JUk4JySKYzDJcx2IHX50trg8CwlDYFAUjChRGkSqEpINoYpXQYBgEUgB2UGZWR3CulmdIJnUC6JJ3agTRGmuueb0hG6RRab56hEaT11YA4/ccs1KdFkLyBzOtCn+bxBdon+bAcl98SHyJtSCp556xq23Xk+fjBff3nqW7qsXLEOFThw2bJgfhLNW6LQ1qmfzBAidCjEKdW+txaxf6OfQAMB3CvrbSrgvPIbBOeSLfgYdT59D3SBoEE3cfchRh580vtms3Y2+x/UHnY/fH33CKaf0cZ9/nu1zFXlLCSmKyqiHvMXFiByNkXOEhYZHA4PQcQ0aEY2KRs8+/gcRY0F4LGo0JkZ6TI/i48ZaqKxUwAgQokdGbpaDISKW8ybVx4rVK64bozHIG0STPEYoRepiRA4yxfQBzyYPkA+P+6c+OBI3I3pWcl98iLwJtQD/XXQnWQGQge4Cfl/4HrO2NPq5R48eXs+ityBO6FDTu6EeTiroY/QwnxRzf7EZHYgZhMwKBM32WwlJHefivFgIMQ6wZiqDYXz56E92220332YIFoOM4srDlCj6lnOx/y9/ac6a3uUg8pYSUhSVQWNkJIVyoBHFjawZxQiUJVjkOjQ8Gg0EDAsa5M4InvlZ8BulQKEB03gpNFZIWCP1tTrx3cgc12TUxkgMckgqj5NPPtn7gjSSnLEaIGsspsx18Wt5+OHGVroAkvviQ+RNqAZ8ctFB6KWjjjrKW8KKAFw+mF5kQI1vMToU/QWRQ7dX081GuiBZZBKAPJG2hLLnnnt6ckhgBgSMT0gY6avYzjFE6XMc/nnIP9G3+FxDLAnEoG5M/6JbccWhJPk3T3nyCbfmmmv6vom2lCVE3lJCiqIypk6d6hsRJnA+kxpalsVIlBWz1tmoyszjccmCaKKA7NoQRp4JlkKijjCxM3VA55lFkAPKBuIGYR0w4JKScmzM901yX3yIvAnVwEosTPExuGTNz2ZEPTYTrNWM7JLfE5cYCBy6k0G5WcOSCrqdQTukzdI7sYwig2SC3EhDhX/zlClTfOE77YLgClxLKHwnNRWElkJdLDCuVrz/3qtuxx2293W69NJLu7ZmA5G3lJCiqAyUPhGZWLawPEGM4obWqQWCyPNAyTDNC7lk5IdTK8l1Cd9vNPePASV0xhlneOW31VbbumefbSx5r+S++BB5E6oBH2CmS1m/9NZbb809qKpW4LuLrzJrN+NXZrMpDITRm7FuZTv7uS9cVLoLH3/8oTv0kEM8mcRyl6W/s8hbSkhRVAZWJKItMT/ToJiyhMg1Oi3Z6sUsgTwDnov57WGNwxmWqQIUFSPFZlnisL5xTa5BGpFGILkvPkTehGpADzClhy8uPrhZWP2bCdayvvvuu/10Knks8W9GX6JDscQZkbOBMQEF+M51l/x++eVX3u8NyyZWQKx/WUHkLSWkKGoDpmoaHKQN/wrIijmFdiKJ455RNuYcC6HFn4NkwDPNNJNflYLABhIBN8v6xuiVaC5kls65EUjuiw+RN6EaIG8EdOHvxcoIrQJmJVjxhuTt+JShO80wAIEj8pNPm+1hiUWIX97AF44UVkaQmcLNCiJvKSFFUTvIvTZ+/HjfqZCkEd8FiBwm8Er+C+1WIKzcM4qFERnRuEwFMDLDL4Jn9PDDD/uGznRns0bDn332qevTp49XcgcccICPiKoXkvviQ+RNqAT0yiWXXOJ10q677prJ0oNZA3LE1C9BCWQSYHoSP2LLNkC/gq5l5R5mHrrDssh0L5kOIJmPPfZY19bmQ+QtJaQo0oMRHh0Ey7EQ2QORQ4HQ8Jg6pFjUJ8WIHSMpK0aEilzC4AjuB/M+8oIyIXgAX8BTTjnFJ8+95557vJ8bUVZZ4auv/u6GDh3mR6JEYdGR1wvJffEh8iZUAhZ9otDRT6wSg0N+qwKrGnKLzOPDx2wGxgH6EgbJ9CEMXBsZsNYL2s6qq67qydvjjz/etbX5EHlLCSmK+vHxxx/7VCJYmxg1QXAgNYySIG2W34fGR2E0BfEhJw+Nk2MgSJA5zNKWKqQZJYmM1VqMtFF/AgSoO78322wzryRJAnzbbbf5SFzM/3kBZT1+/N2lUeCKPl8RHXO9kNwXHyJvQiWgD9BF6NEDDzywsMEKtQIrHNGg6FWCsyzFCHqYGR5SVpHzkuNqQa3HVQMrVmCgIKuAyFuBIEXROOgwyLMD8SHDN4kOWbD3t7/9rSc7JEHE7AzhoAFyHGQI/wZM5Fi0aJxMB0LwWOGAAtHjGFuipFyBIBrR4hNlFpKxWgo+bBRIJUl5GfGZnwP5ghj10XCbtTxVvYAsk9uIOrPqRL2Q3BcfIm9CJcTkrVlkpQjAMMB0JelPyOPGAJpVZtDFyHk1QGRpJ6QMaXQ2hHYk8lZASFE0DjJSk7UacoagGyA6+MmRg4f0GVjoiNxhFYRDDjnEJ1Jce+21/coF5ADCd4xlsnDAXWwxymLeimbEqlzhuMUXX6JEDH/p/w/psn0xSYuLnR8SCPmbZ5553RJLLOnJKAR00qRJXpEUBSgkkgNTZ/xd6oXkvvgQeRMqISZv/G43oHvJ40a/AXliME+i3Uog1x19zk033eT69+/vlzV88cUXuvamh8hbQSFF0TgefPBBH/Ydk7cQjIQYAbEWKaZx/DNIMEkaEkLcH3nkEe83dvPNN3u/riuuGFZqpAM9gTr++OMTC4kf+ezX71w3ZMjlbsSIkb6hQgixoGHdSyJsViBAHEPk7Pzz/8hPl2666Wbuqquu9vVCCRRtNMszY9F8CCqpSOqF5L74EHkTKqETyJuBheDvv/9+v5oEU6qVlia0dCRDhgxxo0aNKvUJl7vBg4eU2sOfu45IB5G3gkKKonFA3szyRidSL4gkguBB7r74YhrBI7M2UVSVCtmzadz//Oe/fKNm6SrM7OV83/CjgNxhbWOalu+9e+9Saui3ejM7uX2KCiyZZFQXeWt/iLwJldBJ5M2AEQACxZRqOTDjQzugDSD3H374gbv88iu8UYB+Ii1E3goKKYrG0Szy1ihYSJgIWCxp+MFBcELSBpmDuGF6n3766b2PHek9sNY999zzmYWhs37evffe61OIQEYbAbne8PsQeWt/iLwJldCJ5K1WMPBnqnXkyJGesJEJYNCgQX4907SzKSJvBYUUReMoAnljtMWUK3WAnEHSIGtWmB7Fpw1LG/51TD1C2mjUWU6NEo0KaSO4gJQifFYy+VeDyFvnQORNqASRt/JgIE6bIOABn2wIHHp49OjRqX2YRd4KCimKxlEE8kanBSGzHHOQG3zasMIRzcqqBwRE7L333j4iNq/ODGsgvhfnn3++XyiZSNx+/frVTeBE3joHIm9CJYi8VQbPA13Pmq+ApOnk5UQPp4HIW0EhRdE4upu8YXVjhIUSw4/NghBIGwKRw9LG8jE05LQNtxkgEAPCxrp41JUo0cGDB9eVcFLkrXMg8iZUAuSEQSEuIay4IvL2bSD/w4YN87qWIDTILu0kDWhH5C4VeSsYpCgaR3eTNxrUpptu6vMATcsTN5cnbzQ48syRUBfS1F1AcbCOH1OmfIfEDR061Jvw0ypckbfOgcibUAk472PVJ9XSQQcdJPKWANoDsx0srYXuxQpH+ieC3GoF7YgMBqxqo+WxCgQpisbRneQNf7U//OEPXeuszu6tbbYoPD4O+JwVIfM406TU85VXXvG/CWHH+pZGiQCRt86ByJtQCeg1rEroXvJmirx9G6R7grDRJnhelv+NrAK1gnbUs2dPn7CddpgVRN5SQoqicXQXeaMxslwK155llpnd+uv3dP36ne8tcVi3iqTM8H279tprvRIhEoroU5JNYspPE+VKqpB99tnHE1SRt/aGyJtQCei/q666yufYFHlLBroVgouFErz99ttuwIABqXyOaUfrr7++22CDDUTeigQpisZBgt0ePXp43zI6kbxA2DcBCBtuuKH3KXv00cfcxx+ns2TlBaZtyU3EKhN0vpA2zPkPP/ywT1xcKyCBRx99tF9ujOzh9UJyX3yIvAmVAHnD/QJn+oMPPljkrQxY2pA2AIg0/d3vfucmT57sf9cCWd4KCimKxgEBwZkzT/KG4iJ6iKnHsWPHNrx+XR548803fdAEoz7M+QQyMH366aefdh1RHZC3k046ya266qo+j1G9kNwXHyJvQiWgA9Enyy23nNt///1F3srgrLPOcsccc4z/Tp5NInMnTpzof9cC2hHEDSOByFuBIEXROLpj2hRLFslvuzMQIS1wmGWNVzpgzPk40V599dX+PmoF5I21YVdZZRWRtzaHyJtQCUbeVlxxRVneKmDMmDFe7wJ0MDMXaSxvL730kp9ZWnfddRWwUCRIUTSO7o42bRVgYWPaFD89gPMsof4QslrBsQQ+yPLW/hB5EyoB8oYvF5GQ6ISircNcFKBvR4wY4b8zbYq7ydSpU/3vWkAid6UKKSCkKBqHyFttILL03HPP/SZpJEEL5GciuKJWQN5YjB9lIvLW3hB5EyrByNsaa6zhjjvuuK6tQox77pnkrr9+uA8UQwdPWw7xua69lYE1k/a05JJLesubyFuBIEXROOhYGP3lHbDQamB6FOdZlskCpDLZcccdU4WtE21K7rrFF19c0aZtDpE3oRIgbxARgpf23Xcf9/nnn3ftEUJMmTK11A5G+QTt6OA0SxTyjMkKgNUNXZ1mujUtRN5SQoqicRBFufnmm3s/LDoQIRmM/FC2rMGKr97dd9/tdtlll1SrPkD0UCKs3cqqEvVCcl98iLwJlQCxwA1jgw1+437728O8jAjfBla2O+643evONOSNaejXXnvNnXfeed6nkHY0bty4rr3Nh8hbSkhRNA5ShWy55ZY+GgfnTiEZRJhOmDDBKwC+E/HEeqy1kjeCHKZOneLD1hdYYAE3aNCgrj3pIbkvPkTehEqAvJEi6ZBDfusGDrzU+3K9++67XXsFA+QNnUuOtzTkDeLGsbQh2pPIW8EgRdE47r//frfOOut403IrdRJ5g3xuEDZSmzDFgSNt7969a542xf9i/Pi7Ss+5h1tooQX9Gqn1QnJffIi8CZUAeTv99NN99Dm65Mwzz/RJe1mFRfgvyAcK6aJtEG1q6ZoqgePIw3nyySf7dsRAmeTotK2sIPKWElIUjQM/AKxuZPpmDc80SWc7CeSiw0rJWqss24UVjinQWi1vn3/+RYmwXeq22WZb/6yVpLe9IfImVALk7bTTTvM5zF555WWfxoL3jmuGBtH/BUFed9453k2aNNnrXZ5PJfIG2SMLAMSN9sZzZlUGZklE3goEKYrGQR4dlmchUSQJEOk0hG8DHwqUKqNArG0kNybbN8l7qwGrG4qEUfYJJ5zgSR+Kul5I7osPkTehEiAVffv2dUcddZSf4sOnFjnh3Z999tk+PQb+yJ2eQoSp0nHjxpfKhG/IWxxt+vXX/3ZTpz7tRo0a7aeieX4PPPCAH3Dj4gKZ22uvvUTeigQpisZB9CTpK/APoKO48cYbfYMR/hcoUZbFQgGwQD0jPDpkW6y+HPB1mzJlijvjjDPc8OHD/RqpvXr18qPueiG5Lz5E3oRKMPLGAJB3jc794osv/KCQ9TzPP/8Cd8klgzyJYwqQpOCsMNBpZO6zzz4tEbEH3SOPPOq/82xoJ7ZkIW3k6quvcRdeeLEbMOASn9D3mWee8TNIpBZhChVCx1KMIm8FghRF44C8HXroob4R4HvBSJBtKBfhvwgtbxA2OmHyNFUL8kDBYHFDUTPFyrTrJpts4tOO1AvJffEh8iZUQkje0CFYlT744INv8pk999zz7tZbb/epLjgGixOygf6ZNGmSn2bFAsUgkkHltFQa/9d2KzW88867buTIkd6oMHXqU+6ss84utaUr3N1331PSv5d53YqljbZC++HZkVCdtEwQYggv+Tn33HNP/+yygshbSkhRNA4aBbnHaCAIOgTulFNO8Q60WebFaTVgQSMhL6lCWF2BzhVfCj6TwLFY2fBpQbmgaDHhM5LGx1CWt/aGyJtQCZA3AhZY7gnyBnGDwFlBF0NEICDoEqz3N9100zeEjzWSyRWJAz+zJkOHXuXuuGOMlzFkhwKp47xffvml119FBc8CqyP3jEsK7QEyynMZO3a8O/VUfAOPLRHYYV5v/v73R5dI7UDvB8eUM8/IrGz4yPH8+DTyRkJ03ILwU84KIm8pIUXROCBv++23nycVjFggGCSgRbEce+yx3kI0evRohbGXgCJgPVP8KVCM11xzzbeeC5Y2LHI4zKJg6bRZogUzP88Xs/5GG20k8tbmEHkTKgHCwqAOlxWzvBnpMAICGUHnULAkvfPOO57IoXuQIxz3J0++r0Ta7ijp71tKMnaVGzhwoA+GQqdD8tBRZBTgeHQV54LoEDEPYULfM8VIwUcMPUXdrNjvr7+mfP0/+6oV/ss57fxci2tiXWSpKwr3xMCWOiLvLBVmbiVE5F922RXu+utv8DMWBIy98MKL/v65F56TPSM+w+dHgbxRsFrynJWkt0CQomgckDdGJYzqEH4b7TE1iOUIBUBDwnzPMXQuJKidZrZ/1o+QaDg0yk4ACgYlgDIkASTPAz8VInUhZihOTPk4ybKEFiNfno0pEvxXRN7aHyJvQiVAbLAIWTqLmLzFBT2C/mAAaOSHbe+887a3PmGxQk5MjpC5++67z8tTqJd23XVX7yaDjKHThw4d6gfuzCiMHHlraeB+t/+fFXRY+Lta4Xj7D1Obo0ff7s9NoQ1ALrlnpjGpB1OaQ4de7UaNutWnYmJgTN3xW6NdvPzyK57gkULFyCfP4NNPPyl9/zZhC4vpXFKwQAo5d1YQeUsJKYrGEZM3lIIJPuZ2PmlMNHaIHAqAhkCj69//Qu8sOnr0KD/6o9GyVirOtZA//tvqwNeN58L9sCDyqaee6pUe1kg6ZyyTZ511lvcVpMPmeTIyhLBBhGNFIvLWGRB5EyoB8sa0Jy4qtZA3K1jg7DvHM3CmoLchdWZRM4d9SB1E6KGHHvIzKhA15IosA+hsLFpWRo4cVdJfI7zPM4U+gbWcr7vuhtJg9EIvl7iKJBVWjMFShvvNqFGj/P9vvPGm0rVG+XNwfga4XBfdybn5DcnDl+2Pf/yTNwRQZyx89D3cC/cEWTOyas8ofA7liulcCCr9Fta9rCDylhJSFI0jibzRMPhOY0Ex0AD4ZAQEiZlmrp/sR2rXXnu9u+yyIb5h02Htvvvu7qCDDiqRu/NKo62R3tQNmSFDtp3XRk80UMzqZq6n0eKbAWGiNNNPw87Hp5nzKZjyURDcI/dLo+c+UXrcK0oPCyQRS4cddpjbZptt/HIrJH5kO0l7sbzRKXN/PCd7bqZoQkUi8tYZEHkTKgEdhDUsLXmrVNA/YTEdDiFCz3FNuzb613Q6ljsKsolux7+OggsIMkkajkmT7vP+0BCgpEJ/wMCd/1OQdXyDmRJG/3N+LGdcE1Jm+hgdDNk0cpZ0H5T4XmsppnNF3goIKYrGUY68hY2ARmUNwUgJZuxppuz3vB+Gme1RRDT8MWPGuQsuuNATOUz1dGQ42zLVyAiNkG8bedGoaPgoCxQIHRl+YkRScQ2ub8WUXLXCsdSV/1MvOkjOzXkhlKZwGI0ySsRPjZGwORGT1HHnnXf2nSf1JVIJiyJKCCJKfjeeE9exZ8Szg5hy/fD5Uez5ibx1BkTehErIgrzVUkLdbnrSCvoS/RUWttlAmwLRqlSS/m/nD+/RSFnc1zSzmM4VeSsgpCgaRy3kLSzWAGmMNAxGdRQaOCMqGjjnYJT14ot/9FYpfBmI9IGsYVLHiRYSx3QjHRVWLaZh+WRKEjM8io1j2Ib/GAXyh78ECq9csf04A0PGyK/Gb84HCcO8z7nsmtRh8ODBnsDhl4GJn7pSmAaGiKJcIajcrzne2n2zDQWV9KzCYopEAQudAZE3oRK6i7x1UjGdK/JWQEhRNI605C0u4QjKCueh0UDmbHoSosM+LFZY1LCyYQFjWhKChzMpJI8cRpAmI3xYvKzgNwH5q6Xgz0FHyCekkfOZMy2Fhsy1KVjjMO1jPYR08gwgoRYxxbQqBI37snsM7z1+JkmF58F58QnZfPPNRd7aHCJvQiWIvGVfRN4KDCmKxtEoeatUQnLDuc18zjUwsUOQsGKFIeRY8Ch8p0AArYTm+WqF4+3//A7PbVZCuzbfqZOZ+E2JpiFn1QrnZhoBcsqC9gQ+1AvJffEh8iZUgshb9kXkrcCQomgcWZI3lf8WI4VYGQmTR2nXC8l98SHyJlSCyFv2ReStwJCiaBwib/kUI29M0xIMIfLW3hB5EypB5C37EpI35XkrGKQoGofIWz5F5K2zIPImVILIW/YlJG8sU4jfc1YQeUsJKYrGIfKWTxF56yyIvAmVIPKWfTHyRloqVnMgcC0riLylhBRF4yA1Bp0MJE7kLbsi8tZZEHkTKkHkLftCgBjkbfjw4T6xOqmgsoLIW0pIUTSO0PIGwRB5y6aIvHUWRN6EShB5y75A3ujPzEBBH5cVRN5SQoqicZAQd8stt/SCTToLkbdsishbZ0HkTagEkbfsi5E3pkuPPPJIkbciQYqicbDawIYbbijylnEReessiLwJlSDyln0x8kZyd5G3gkGKonGwHBUZ/xFsTZtmV0TeOgsib0IliLxlX0TeCgwpisYh8pZPCcnb7rvv7tdgrReS++JD5E2oBJG37IvIW4EhRdE4RN7yKUbeWGFh5513dscff3zXG0gPyX3xIfImVILIW/ZF5K3AkKJoHCJv+RSeLZ8PPvigO/roo90ll1zS9QbSQ3JffIi8CZUg8pZ9EXkrMKQoGofIWz7FyBtLtJx++uk+RUu9kNwXHyJvQiWIvGVfRN4KDCmKxiHylk8JyVufPn3cdddd1/UG0kNyX3yIvAmVIPKWfRF5KzCkKBqHyFs+ReStsyDyJlSCyFv2ReStwJCiaBwib/kUkbfOgsibUAkib9mXkLzRFkXeCgQpisYh8pZPEXnrLIi8CZUg8pZ9Ccnb7373O61tWiRIUTQOkbd8ishbZ0HkTagEkbfsi5E3lsc67rjj3OjRo7uefvMh8pYSUhSNQ+QtnyLy1lkQeRMqQeQt+yLyVmBIUTQOkbd8ishbZ0HkTagEkbfsi8hbgSFF0ThE3vIpIm+dBZE3oRJE3rIvIm8FhhRF4xB5y6cYebv//vs9ebv++uu73kB6SO6LD5E3oRJE3rIvIm8FhhRF4xB5y6fElrdrr7226w2kh+S++BB5EypB5C37IvJWYEhRNA6Rt3wKzxblTAd+8sknuyFDhnS9gfSQ3BcfIm9CJYi8ZV9E3goMKYrGIfKWT0Ex83xfeeUVT97OO++8rjeQHpL74qOZ5O3VV1/156kEyMDnn3/uPvzww9J5/uimTn3GPfHEk/6ctOePPvrIffnll11HZwfJZm0Qecu+iLwVGFIUjUPkLZ9i5O2tt95yffv2deeff37XG0gPyX3x0QzyNmLECHfUUUf59gj+8Y9/eBli38SJE92oUaPcjTfe6K644grfjs866yxPBvbee1/Xq9dObptttnV77bWX77gYMDBV/9VXX/lzZQXJZm0Qecu+iLwVGFIUjUPkLZ9i5O2NN95wZ5xxhn/u9UJyX3wcffTRDZO3sWPHul133dUNGDDADR8+3MvMqaee6g444AC33nrruWWWWcb98pe/dIsuuqj7+c9/7hZYYAH3k5/8xM0555xuttlm82WuueZyP/zhD/32Y445xlvnsoRkszb861//chdeeKF/nyJv2RSRtwJDiqJxiLzlU2LydtFFF3W9gfSQ3BcfJ510kreagXrIG78feeQRt9pqq7kZZpjB/eAHP/AkDGI277zzuh/96EeekP34xz/2n3FZcMEFPaFbaKGF3EwzzeSWWmopd88997h///vfvk5ZQbJZG7744gt35plnuhNOOMGTN3SDyFtzi5E3lsc6/vjj3a233tr19JsPkbeUkKJoHCJv+RSRt87Af/7zHz8lBnlj6hTUS94efvhht+aaa7pZZ53VzTfffN8Qtp/+9KeelP3sZz/zBZIWl4UXXtj94he/8PtnmWUW17NnT/fuu+/6+mQJyWZtwDfx2GOPdUceeaR76aWXRN4yKEbexowZ69c2xcUgK4i8pYQUReMQecuniLy1Nz755BP39NNP+9E9pA3SdPDBB/t9jz32WF3k7aGHHnI9evTwljYjY2Ept80KvyF8WOGw8Hz99de+PllCslkbIG9YZg877DD38ssvi7xlUHjG9GcTJ95bes6He9/QrCDylhJSFI1D5C2fEpI3/FwUbdr6wJJ1xx13uEsvvdT7uG222WZujTXW8FYx3hG+aSAkb3TUEDOsLUyXGXnjeznyxlQpFjd82sKCBQ5iZoXrhoSO70y1Lr/88g0lhU4DyWZtgOwfcsgh7tBDD3XvvPOOyFsGBfLGc8b9gAGVyFuBIEXROETe8ilG3t58800/pQaBqzd1g+S++4D1imlQ8vSRxmOdddZxSyyxhJt//vnd97//fTf77LN7YsU7Kmd5e/755/33qVOnfkPeIHWkBJkwYYI7++yzvzVtivWNqVMrXG+eeebxxG6OOebwBaKGbxzf5557bv/9u9/9rtt4443dM8884+uSNSSbteHTTz91u+yyi9tvv/38d4hGkt5Qqb8YeXv0UZG3wkGKonGIvOVTQvL2hz/8wU9joVjqgeQ+f/z97393TzzxhLvsssvcVltt5QkURA2ixHesYKHPWUzehg4d6qZMmeImTZrkrWCDBw9248aNc6+//roncqQFYR9BBVhlIXSkA9liiy3c9ttv7/bff3/f0Vvh9x577OG23XZb33632WYb/7nyyiu7FVZYwVvbIJWLLbaYHyxQ/zwg2awNELaddtrJ7bPPPj54QeSt+UWWtwJDiqJxiLzlU2LyduKJJ3oFXg8k9/mCaS3aB+0ECxhWLaxrYWQnvyFxWMP45B0ddNBB/v9Y6oYNG+Ytbdddd5077bTTfK4//ONoa+yHzJ92Wl83aNAgb3nDEjdy5Eg/rYYvHR0RxzJVS3nvvfd8zsDnnnvOPf74437KlfPffPPNPp/b5Zdf7v0qSTPC9GtekGzWBtp+79693b777vtNcuUkvaFSfxF5KzCkKBqHyFs+ReSt9UDUKFOXWLqWXnrpb4gb6TkgbBA3iwBlGpPv5FzD8jXzzDN/Y3mDnJnlDesd55w8ebJf55YpVMjZPfdMdEOGXOm23nobPx0LQYOIkSsOP8lKIMLVQJ1J5ouljWl5kvKSUywvSDZrg8hb9kXkrcCQomgcIm/5FJG31gIBBFjIyLMGOcO3DKuaETWmTPFxI6qUhLlMpUK6rr76ak/Kdt99d99hAMgbFrCnnnrK+7Xh90ZHAqFjqnTgwEvcuHET3HPPPe+vSfoIjkuzPFZRINmsDSJv2ReRtwJDiqJxiLzlU4y8WbQpy+KIvBUP77//gRs27Bq38847+4hNcqRZIADfZ5xxRrfccst5XyXeIx3C3Xff7f3WIFnmW8b7tSS9TGlCwlgxgfcPgcefjSWrdtxxR3/cxImT3LPPPuOnSSF6dDrkpeJ/Wpi+/SDyln0ReSswpCgah8hbPiUkb2RWp6BY6oHkPhvce++97pBDflsiZ8t7sjb99NP7gASmQn/96197HzYIF0tVYT3D0bwc6CwgYoA2xX/wZcMyRzoQoj/xTSNdRP/+F3gfNaxup59+ug9WAOwXeWtPiLxlX0TeCgwpisYh8pZPCckbC4jTkYu8FQcPPvig22ijjdx0003nny9rghK5SUQg74vgAjqDWkFn8dvf/rbr1zS/NCJKzz333FLp5668cqhfc5E8cddee52/xvnnn+/efvvtrn84d80114i8tSlE3rIvIm8FhhRF42CKZostIG83irxlWGLyRhF5635AqggkIOWG5Usj1cd2223nrWWk8qgHMXkzQMTuvPMud+ONI9wNN9xQ+rypROLGen+4OLAA8kbAgshb+wHyxsAA8qZUIdkUnin92aRJ97nDDjtC5K1IkKJoHP3793ebbLKpGzHi5hK5mCbsIm/NLyJvxQTkjGADAhCYKv3Nb37jozxZF5HIzXrBWopJ5A0QDUokKJ02hYjQpAXjmTblHK+88krXluJDslkbIG977bWXX4UDkkFBRyTpDpX6ipG3cePGl9rj7/1gKSuIvKWEFEXjOOusM0sd1kbujjvGfrOQr8hb80tI3pgy1bRp9+Pzz79wgwdf4Vcw4JkSPEBOtEZIm4EghHLkrVbgB7f33nvL8taGQM9iVcXnkfeLfhB5a26hP/voo498vkSWrxs9enTX028+RN5SQoqicWABYk1GMrsj6BSRt+YXI29EGvLMFbDQ/SC/2rrrru8DE2gD+MY0C0x57rnnnr5d1QOWxzrwwAN9Shl8oloFks3aAHljah1yTu4/dAMlSXeo1FfQr7Sdfv36uR122MGTuKwg8pYSUhSN48ILL/QBCwi2mZlF3ppfQvJGGgmWLGLqpB5I7hsH05YodXK1If8kzm0mWJXhjDPOcFtuuaVfrzQNSDtCZCvRqnxvJUg2awPEgmCUDTbYwI0aNcr/xlKUpDtU0hf6MIgbLgm77rqr+9WvfuUDhLKCyFtKSFE0DqJNsTqQUwpyIfKWTbFRNY7p+EP16dNH5K0bwVJS+LeRhJdEuVmApauwnrEAOeuZPvvss2XfOcEKTJ8R1YofFFa7+++/v2tv60CyWRuQA6bVF1lkEU/y0buUWG+o1FfQt8wiYV2nna+00ko+sjsriLylhBRF42CB7F69ennLm8hbdoVRNZbN2267zT9vVlnA+lMPJPeNg3xrq6++upf7cHmpZoM1SPFvJJqVaTKCECCLTJVB5iCRLJUFaSONCLLBCgtMm7YiJJu1AfLGII4VO5g6NWKPnpD+bbzwLLF+455Csm0GaWPGjOl6+s2HyFtKSFE0DhbMJi0CYdRM7WG+l/JofrGR9cCBA90qq6ziO/J6HeMl940BKxdKnemUpCjPZoPpG9KRME3LygwQNNZLPe6449xhhx3mtt9+e7+iwznnnOOnb7EYtCokm7UBcsH7n2+++fwgYtCgQV7vsl36t/7CYOmzzz7zz5CBMkmvIW+sN8wKJ1lB5C0lpCgaB5YATMp0KiyGTeoCKY/mFiPFTIvZVAmWN1JG1APJfWPgPTCVufXWW/vOMi/QrrCoPfbYYz6qlTVPCZLgkwXq6XhaHZLN2oDcHXvssW7BBRd0G2+8sSf2WIGREfQCeoPv0sW1FZ4TepbBGINk+jWWr8P1YN1113WLL764yFuRIEXROK677jpvumdkwlQO5I3pUymN5hSeI4oahUL+sLXXXtv9+Mc/dn379hV56yYwIl9mmWX8ovJYP1577bWuPfmBNVCZ1qGttRMkm7UBnYD1naXXjjnmGG9xveiii7zvMcuj4WKBWwWDPkiJiNz/lvB5YKmm3+L7n/70J/8MGRzfcsst/jnj081zFnkrEKQoGgcpDZZcckm37LLL+rUVWVzbGoJK44XOmWkzLC4QBUjywgsvLPLWjRg6dKhbaKGF/ILzP/3pT/0UJs7M8QoHWQLfJjppIlHptC+44AIf1IAPHHKTZ10AU/hYABtZVQJINmuDkbcFFljA6wWeP871RKKzTBqWWYgIy6VBTmwAiNygU6xA7GKd066Fe+WeeQYff/zfZ0LuzBdeeMGn5UGv8jwnTpzY9aSdj+gVeSsYpCgaB+ZlTMpYg1iuhbB18xvoJMWQReH5QdBwRiaiDMVMItill15a06bdCAYsKHMszvgcsbrCGmus4c477zwfPMC7yxpYVbgOnTSRx5tuuqlbccUVfWoRLDGk8CGogqzwTKc98MADfjF7Vlt4992/ljqwj2oKeGEaiXQJDCD++te/eTLAovoQNRy4WW+Va1hak91339N3hPVCslkbQvLGJ/j666/9+4VAk0qIwrt56aWXvE42axPuLfbb9AyWOivtoLeNqIX3ROGe7TuF50X7gLCRE5EBEKTX/Il5piJvBYQUReNA2Oeff3631FJL+Wk9OpKLLx5YGn2/5ad2aDimNJIamcr/FlMudJaUu+66y/u5HX/88X5aGiWDz9sJJ5wg8tZNgLzxDiBvrGNKBzrPPPO4mWee2S9Gz+idaSw6yDwCGrCy4ZtDWpEf/ehH7rvf/a6vCzno+G7kksCigw8+uNSpn+r69TvPBxnRIfFfSGdcWGyfKFZWahg06FJ32mlneLnD0rj++uv7+/7e977nvvOd73iZYip59OjbSx1f/VY/yWZtCMkb2f/DiGcsbS+//LJ/f1iJ0R0Q+ksvvdQTbixMWJaQUay3WJ4gOpyTaVazyMUlSV91d0mqpxWeA0YELG1vvfWWJ7Ho0HHjJpQGNtd4nzae3ZAhQ7y888ywxIWgbYm8FRBSFI0D8jbnnHP6UGoaPmkMjjrq6NIo5iQ/lcQoD9AIaBihYrAG2InELrxnnoUpT0Z8TDsTXUgaFhJxMh3NbxQ0nSdTdYwSRd66ByF5YwqbwjQqg5h5553Xb1911VX9Eld33323bxcMZLIEJJHOig4J+YC8UR+rE5ZxiB11s+/Uefnll3c9evRwa6211rfKr3/9az8os3vif5AFPilYHSGtM844oyexl1xyibfSNQLJZm2IyVu5QQJT2BATyBqkbfz48d5PmchkIlSRZTIGMPWOtRZ/L6y0WFjRL+gjLLQMJJEvBuPoKiumyyuVUO9VK0n/txJel3oYOUNfInf0MbQzBk3MVnC/DDxYf/uqq6765j4HDx7iRo0a7e68807fX2F9K5fuR+StoJCiaByQt7nmmst3AjQocO+995YIRx9POi677DLfiJ56aqof+TACovFB5Gh4KAZzrDXzNo24nax1di8U7o+RoN07Spj7ZvRLxCCKFuXKFBzTpEx9oYwACobcTkSYibx1H5LIG+kE+OTdQHZoE3zHEsfSOvghQcB591nmhUOWuBZT63PPPbcnVRSImhEvCJ0RL4qRvKTCOeaYYw5/T/w2Asi9UTgP5yfyEVluFJLN2lAreQvBFCD6iGnt++67z1veiFZmgMH0KpY5CjodGYfgkYQdax3HY7VCRxFtjb5ClzM4J3CG8xqpigu6nvqi46sVI4hW0JdcA93J9VhhhgAh7oH29NBDj5QI6QRff+pKrkMsygQbMH3MABjSBmnFEknfRKJz6loLjLwttthibty4cV1bmw+Rt5SQomgcRt5wpKcBG1Am+OPgdwHhOPvsc0qjn2F+GgYyR0NiP2kPUAg0SJQAjZeRFCO9sDHb6MvIXVGL1dFGiNQfxcX9cF8oMo5DAaIMUYooT6acsVzwvEiyynQH5wmBIkFRi7x1L5LIWxKJgxjNNtts3jL9y1/+0ncCrH6AJYBz0A6Q+XrfYznQXphqh3hhhbN6xYXtkDojYkmFiNqk/7Md4gax22OPPXygUjMg2awN9ZC3SmBAwTkZYLOk2k033eR1DANw/Jr5jW/YzTff4n9feeWVJd1/ndfnWKQgeOgxBp8QJCvoN3Q9RBF9X66wn+M4B1ZC/kfhOxYy3EcgZBAzrg1Zw0o4fPiNJXJ2tSdpuCugPyFrnJMpYUif+a/VAyNvtAEtj1UgSFE0DkY3dBIxeQMoFEgLDqB33DHODRo0uDQyOscvrI6DM74YTC3hJ2ejIxQHjY7O4J13po243ntvmsXKCFE4MsOSAUHik/LffelN+kn7rSRdM76u1Y9CvemYmX5gtMj98ByIBsRUjzkfpYsvCkqHLPooIKYssMolKRyRt2KgEnmzYuQIkgOBoo3gH8ZAZ4kllvC5ETfZZBO//ihTnVgNBgwY4GWAjoqlsfDBQfZsWigNCCQgChyCFdet0cK9YcGbZZZZfIJgBmDNgmSzNjSbvFUC18LShqVr/Pi7SrrrCj8zMHDgAK+3IVF8Qur4zoDeCrMItBdmECoVjuEc+J/xSb/C//lElilMfdJ3EFlNuh58NWknNsWbBYy8YXmmPllB5C0lpCgaB42K6RSmTWPyFoIpwg8/nLZ0C6SGjgmL2+OPP+4jVPFFIJs1nRnZ4iE1V155VWkfjfQB78NAlBsWK8gQU4kUiJIRKCNUFLZXI2Qh2bJS7rjw3EbWKNPI5XtegWA95L4gn0xHQNJ4PlhauJ/evXt7Z2+IK4oAokYKEP7LeThvpVGiyFsxQEdj0aZJ5CapQHiwckHkIFSQOCxypBvhu01hck6CAXbffXcfgMAAB3LPig5YZuncsDpA8LBMYOlA1pgKIlUEhQEQ/8HalwV5g5D+4Ac/8EEQzV4/VbJZG/IkbwaugQ7Cr4zBBJ8U9BCfzJSgK003mn6E+KEb8b+rVtCF6Fx0IedipsKuQeG6FPQk08BZ3zfX2HDDDR0DFQZWWUHkLSWkKBoHIy1GJUmWt1qBIqLhQmQgc3RId901wZvEBw4c7LOHYw7HQgcRYokonG0pWCtwtMW3buTIUW7MmHGlgpn9bj8tyTkhU/hIUPhunRwk0AgadUfJsB9SacczjfDMM8+WRpz3eOshpnNGilwTawmdqdWBeuFvRBoP6so2fEg4Hn8JyBwdLdfgemkVj8hbMcC0DSQM61MSuam1QILofCFsYWEwZMQOkjTrrLP6guVuhhlm8O8fXzqWSSNQqGfPnm6bbbbx659SSCoKceM8EMaka9dbOB9WRAZrtP1md56SzdrQHeStXjAlW2spGoy8EQCELs8KIm8pIUXROCBTM800kydvkKBm4t133ysRqD/6nFJYGiBARLCOHj3a+4hRMKvjHwZ5u/TSwSUidam7/PKhnlgxFYl5H6seBXKF9cJIFpY+rGCY4vmOdYPjOAZiyHHcH2kVzjvvghIZG1Dad6nvvLG+MCWAHwaFOuGbQdJUpn+xijDNwFQpo89mKCaRt2KA6SGIFyQGZ/0kkpOmWFCBFfNDgyBS6KCN5FnggEV8UozwWTESyDmSrldvMT83vmOFwJrebEg2a0MrkbdWhixvBYUUReNgWofniA8PZvKsQWOi08CXjoISYyqTSKTnnnvePfnkFO8HgcMqzrQ42eIfgcUMp1oIIOSK30b68D8zXwuO5RgKxzOly3mYHnrssSfcU0897S10XJdpAvzTzIyftQIVeSsG8F9kShNnfaIvIVjNIHFhscCAuLDPCJ4V5MEIHoX6QLTiczZSuCbEkWsRhZhVW5ds1gb0DhG+vGuRt+wg8lZQSFE0DpLG5kneOhkib8UBVlVWuyARLtObZulqNomrtSSRvGYWrIyQN9q75W7MApLN2oAv2GGHHeYtoSJv2UHkraCQomgcZnlj2hQHUyE7iLwVCxA4IkWXW245P10JiaMzxRoG4cmKSOVdCKjAosc0XdaL8Es2awMzDQwe8MXivYi8ZQORt4JCiqJxEEXJc1xvvfV8hJCQHYy8QQ60tmkxgC8j0+2shLHOOut4Yk2H+r3vzeStVfiksY13ZlOZrUDqrH4ETmBxw8pDJGDWkGzWBgKxCFSBVOC3W0Rn/3aAyFtBIUXROEjAy3MkBQZ+GEJ2gLzxvOlYsfiIvBUHWJ3xo8QKQl6opZdexi2yyKLeJw6rHGlA5p57Lm+ZY4oVS1ZsoUsqIaHKq3BdC8iAuO2zzz4+8CYPSDZrAxHrDBaYpieBrpANRN4KCimKxkGSXZ7jEUcc4QMIhOyAIsHyRuePpadeS6fkPhswdUXwCmlgHnjgIXfOOee5nXbayZM50npAiiBtFiEKsYPU8WnbLOAAax0Eis65kZJEzioV/gOppF5Ml7IiBLkL84JkszZA3lh7lmXQiHAXsoHIW0EhRdE4jLyxHI/IW7ZAkWDZwSKy7777frPmaVpI7vPBxx9/4iOTSTDNsj8XXTTAHXPMsW6vvfZy2223nc/VRqdAmX322X30KtOUZvHCSmekjs9aCscaCUwTcQppgzRyDurBOWjbJMbOE5LN2mCWt8UXXzzTZZs6HSJvBYUUReMQecsPKBKi/ZiG23///X3+uHogue8efPTRx97RnMTPpLMhGTW5AklVM2DAxe7kk092hx9+lNt7733cVltt5SO4scBBrrCG1VKw7rF01zLLLOOX4bL/VyuQNUgbSYG5LqlzqGvekGzWBhKJr7vuuv59sVyUfN6yAdZ0yJuS9BYMUhSNQ+QtP0De8HWjQxZ5ay/8+99fe7+5119/073wwot+JQ5yDrI6B0mBbQ3IagUySPLqQw45xFvTIGVJZA2rHAVrG1GypDxZccUVfWACeQ0bWcy7EUg2awMr0hBtSoJ0XFaKRN6oC/ITLp8VRsP+61//3Ycfb5HBffzmN7/xlnEWxc8KIm8pIUXROIy84YMl8pYtIG8su4WFhQARkTchCSxkT3vEkgY5C0kbljlIHX52dEhYbpZddlk/DQ/xY93h7oRkszYQHGZWeNaDRjc0A5ApSJWRLYgXU/+sl8v6uSREBxA08nriEsDygW+88ab39wQkUSfAhZVxHn30MU80bTBAcvOnn37GPfzwtPV4Lb0U12OFHiyK/I+UNGEduC657bhv6pcXqB++hQyYWUknK4i8pYQUReMw8oYCEXnLFihosqrjCyXLm1AOTO+wtin+c+b3BmGzYAR86igsrr/FFlt4i4J1yt0NyWZtgMCwnB+kYu+99/bEphogXEbOKEb4IEkEP9l0PmlIbOkzEjIzhY6P5u677+6JFeC/EDqWEzz//AtKxP8G9+ab01LJUJd7773XW4yvv/7GEiF74Ztrvf76G27kyFvdsGHT1nu2wQLED79QrIhYulii0MggpI7zEZjx4IMPejJo4D4gWNSTFW+aRWIN3CPr+OJKwJKHWUHkLSWkKBqHrbCw0UYbFaYDaFegmIg2xamcaWobtaaF5L59gcWCxemxqNGxY2mDsFm6Ej7ZTgQsHe8rr7zS9A6vEUg2awNE7KqrrvIEfOONN3YvvPBC157ygFRNnTrVr8HMcn/k7YO4QXrYxjrOrNn82GOPfUPesHT95S9/8QESkDssZ4Drsw/y9fbb77j33//bN6mLkCeOQz998MGHpXNNI2Hg73//hyeKEDLqYxY56kH/wbUgkJw3tLxhkZs4caJ74IEHvvHFZD91hfBts802PqCgXp2YBMgjbQTXA8hrlulyRN5SQoqicVx44YXuu9/9rveXyTNJL40eBQJoZDRoGjhKxurBMSgBtqHcMP+bUmLEZiNNCvtMkaAsUEx2bFHAfTIdRmfMCgtMj9UDyX17gk6T9rjYYot5y5oRN6ZIscIxTUqE62mnneaeeeYZL+NFg2SzdjzwwMOuR49fewI3fPjwqv5j6Ej8IbGkESxDtDo61KZG0YOQJ/SnESfTsd0N9DX1guAZSaRu3ANEdOzYsb7+Zq1rBrjeHnvs4Wc6+vbt29RzxxB5SwkpisZx++23uYUX/rlbaqmlvLk9LehwTOnw/c0333RPPPGEH1FhHrd9kDB8DmhEV155pU9hYAqGhcIxwd9xxx1+dMY5aNg0eEgbDZtw+scff/wb6yDEBwXGdhagx/8Cssb/yNOFQiBzPiNRlkGyeqDc7rrrrlK5xz355NRv1nP9z3/+XVIkfy0d+3RpdPt0qU6vNZ38kW9rhx128JaTc88995v7TwvJfXsC+SAyjgAEUoVgMcACx+fmm2/up9mQ63qn2/OAZLN2EL187LHH+cHzzjvv7K1ZBqxq6K7rr7/+G5KONQzrEYNcLFRGgoRvg75j1KhRbskll/RTpuj8LCHylhJSFI3jiSeedOuv39MTitGjR1clFJAjRoDjx4/3pApFYhYkLF+QNkaRI0aM8NYBs4YxHTRo0CDv30EnBHmzUSGjRnwxIGoQOaYB2EddIGJcg1EZZNAIFWSM3+yDdDKCM2sehOzhhx/2vkADBw70/hZWD44fPvx6N3ToMHfbbWP8lAEgWvDpp592l1wyxF144SUlIjm2qZ0kxJZnhuWEkTZKuV5I7tsPyPpll13mrW3kpJpxxhm9pY10EiyfhDzTLooOyWY6jBs31ltWKSNHjvTb0HEMdJlOZGq1iBbWosMGQtNNN51fipB+JEuIvKWEFEXjeP31t0qEal/vT8NUXpLPAYEMZtWCNOG3wDJPJ510krcEGKGCoEDsaDhY2uqdFswa3AcdIfdqFjm2Mdq9556JJVI3tkRCH6/JibhWMBI877zz/PQXTuaQyHohuW8/WNLW733ve74j5zv+kfgymZ9SK0CymQ7MMhA0hrV100039YNf9BLO/xZcIKQDwQ+kZGJ9YvIlMiuTNUTeUkKKonFAWoYOHep9a1ZbbTUfDWSA2EBo6ECwfNkUKcSHDgVyZtYuA9/D360E6v311//y98i9NvM+sDziZD7DDDN4J9p6p0yB5L69gG8ORI3UIHQ2WFwYILUiJJvpQRDC1ltv7Qkcn7z7LP2z2hX0Rcze4FeMuwGrV5A+p9nuL0kQeUsJKYrmgOlClAZRkJiYbbqQgIBTTjnFO1HTKFqZmHUn6Jz79evnndDXWmst99BDD3XtqQ+S+/YBgwR8OZGLXXbZxSfYbabFN29INtODgRz+u+uvv76fMicv2Y033uj9e5EPoTJ4fjwrgjlY2YTVFEixc+mll7vPPssn/ZXIW0pIUTQHjPJuuukmvx4jvm/4WzBagbAREMCUTlGnQIsOni2BEzjO4niO31+j+fQk9+0D/DMnTZrkg3VwOTDfzFaFZLM+QNLIQ7beeuv5VRfwfdx+++3dxRdf7OVCSAYzGvgF7rTTTj5Km5mNFVZYwQd7fPppfr6CIm8pIUXRPOBnQe6xacvsrOAd6rEYCfWD6DHIGmtUzjrrrO7444/3/hiNQnLfPsAXkrbXyDR6kSDZbAxE6jP7waoZBK3gi4y7xYEHHujOPvtsHwhG4BNEj0AtHPHzmBbsDjDLQ/tAj2JAwAeQbARkJiAQ7YADDvBkl8hsrG0EgpnLAf/LEyJvKSFF0VwQAXrAAQeWlMb3vKVowIABfupUSAesbUQHHnPMMd75HMVy8MEH+1FiMyC5F4oKyWbjwJ8YSyz6g6lUZkR4rt/5znf8cmlLL720+9WvfuUDnyB1kL3zzz/fp2Bi0M2UKxH2BEUROEa0atEsupArZnNY1YEAt8cee9S7DJCpAD81VhmBrOK2w+o/TIfiWoBVjb6J6WWeyeyz/8CtvfY67ve/P8ZH61rqp7yRp9yLvAmJeP75P7rDDz/Cj/hwoCXzNSZonGox34dZtYVpYITIc4H84rtCKhSCP0j1wNJGJ5xwQtOIG5DcC0WFZLN5gNwQKcm0IBGpvXr18qsxkD6GpOq4uOCnbOvfYnliupXvkLvNNtvMr6HMknwkdmYwDilCn0PwcJUhGA1rH8tI8QnhY9UOUjalLeg/cmoSMcv58O0lByfXolx99dWeYBKwBSljJoJMB+S+XG+9df0Mhd0HS8FxfwTS8cl2rJE9evTwKUDw0Ya4Dho02D3++JTcfNvKQeQtJaQosgFEgySyq6++uidwpC9AGWCmPuuss3yjp4GyqDGjJiJSGfFgvm9XB1sIKyNYgjkI7yfHHPeOhQ0FxfNCoaBk8FkhOAHlecMNNzQ9T5PkXigqJJvZAh3LIBq9Q5YAUmIQqYxlv3fv3t5Cxdqi5mNLmXfe+XyKInQ57htMx+Ibxrua5iazotfvJLNlinbHHXf0wTO1ll133dV/sqzbqquu6kkW+SwhkuhCrkXh+2yzzeajqueccy43//zkt5tGPiFu9DebbLKJJ6msw4rF7fe//70nnhBYBsYQyyLmOxR5SwkpiuyAkmD01KdPH9+4scShADDhE4KNCbtnz55eUeBYy8gQ/y7M/Yy+WMmAxLlYpCxPHBnBIUGk4sDHh5J39CrXs2tTD+pDoW5Md1JX6kz0EsmDuRf8LCCsELS99trLZ7snJxNTGigrpjHCbPiQNhZmZjTKNZoNyb1QVEg28wO6BZ2FhQ6dhb7CzYVAs3vuucdHX1599TWuf/+LPMnD0nXQQQd5fc1Ak6hWLHfodissJWVJg9MW1t2lf7ACScNyBqGE2GFhO+yww/xMRJ8+p7mBAy91gwdf4UaMuNnntYOQUneMB0z3QtK4N+6Rey1ypgORt5SQosgeKAWWZMFBFnP3brvt5knLmmuu6UdrjJhotDRUPgnRhtxBaELfjP3339+dfvrp/hyY7lEs+CiwbAmpEh555BHvkIpVC9KHYz8NGEsXjRjyRyNOKuY/AeGy//HJeVAETAfgxMonSoJrQ8Yw4RPNRZ1Qbig2Rn3UmdEjObe4F0aQOMViTaNwj3Zva6+9tn8WrBzBtIAtC0Z9soLkXigqJJvFAEQHwsNC8p9/Po3coR9x/kc/MluCbmSalFRRTM+if0m6Xk/BKoaOZbDL+awQaIClkOtxXYJzqMc0YvZlSa8Xn5jVApG3lJCiyBcQJSxqNFBGSRAvfBlwlsW8zbQqozpM71jrmELEVM97ouBkCsljhMeIDL8GzPs4oS633HLeT4w1/vbcc09vNocoQoqIIDruuOP8iI3RY1zYjl8HZnYWIuZ//J/zMNqDYC2//PL+Or/85S/9dbk+ZBNrInViatjqOddcc3myxvHrr7+e23jjTdxOO+1SIqAHeF8NFoaGAE6YMOEb0omVLS8FJLkXigrJptCJyFPuRd6EpgHLF6MpLF34gTHiYhQGuYHcETWEZYvltyBiWOHwk8DKhRWPaKGVVvqVJ0z4P0CsKExBYo7nO9avRRZZpGxhP/+FkIXn4DdTA0xv4uzao8fabvPNt/TXh+jhK8JSX0RsQcyYGoWYsW4rI0oCNZ599rkSOXvdvfvue37EmMVUaBpI7oWiQrIpdCJE3lJCiqI1gQWPHHJMbRL0MGXKUyWy95C79tprv5nGJDKqf//+nkydc845NRdWMrD/cy7OwfQoy35hMWQh/pdf/ou/PlMJrRhgIbkXigrJptCJEHlLCSkKoRMhuReKCsmm0IkQeUsJKQqhEyG5F4oKyabQiRB5SwkpCqETIbkXigrJptCJEHlLCSkKoRMhuReKCsmm0IkQeUsJKQqhEyG5F4oKyabQiRB5SwkpCqETIbkXigrJptCJEHlLCSkKoRMhuReKCsmm0IkQeUsJKQqhEyG5F4oKyabQiRB5SwkpCqETIbkXigrJptCJEHlLCSkKoRMhuReKCsmm0IkQeUsJKQqhEyG5F4oKyabQiRB5SwkpCqETIbkXigrJptCJEHlLCSkKoRMhuReKCsmm0IkQeUsJKQqhEyG5F4oKyabQiRB5SwkpCqETIbkXigrJptCJEHlLCSkKoRMhuReKCsmm0IkQeUsJKQqhEyG5F4oKyabQiRB5SwkpCqETIbkXigrJptCJEHlLCSkKoRMhuReKCsmm0IkQeUsJKQqhEyG5F4oKyabQiRB5SwkpCqETIbkXigrJptCJEHlLCSkKoRMhuReKCsmm0IkQeUsJKQqhEyG5F4oKyabQiRB5SwkpCqETIbkXigrJptCJEHlLCSkKoRMhuReKCsmm0IkQeUsJKQqhEyG5F4oKyabQiRB5SwkpCqETIbkXigrJptCJEHlLiawf2C9+8Qt/jUrllVde8YXvG264Ydc/i4X4Pqiv0LrgHWaJdpF7ENb5/vvv79oqZAWec5ZoJ9mkblbns88+u2ur0IrgHeYFkbcaMXz48G8aWKj8+c42lIR9R7EUFVZHq7PQuuAdZo12kHurf1gk+9mCZ5w12kE2Q+JmJbwXobXA+8sLIm81opyiAIyWWqUzMGVGUQfW2pDcVwd15B5AKPuycGQLyWZ1UOdQDiWbrY885N4g8lYjkhTFgQce6D9bCWEHJvLW2pDcV0cs42bpMEInZAPJZnWUk027F6H1kIfcG0TeakSsKGh44XXtNyU00Yf/CwtKhmK/GW1Rwt8g3ma/Qx8O20+pRshE3toHvMOs0S5yb7AOUrKfLXjGWaOdZNPqxPWF1gXvMC/kd6UMkccDK9fgQ9gxpiji39bIwwbKPraZYrDOxX4D22bb+U0x5WTnN8VTCSJv7YNq77oZaBe5N8TXELJBre+jEbSLbIbnoqCjhdZEtXfdTOR3pQyRxwMLFUXSKA+UUww0ThDvB2kURahggJ3ftttvrlMOIm/tA95h1mgXuQccF9ZByA68j6zRTrIZ6mWK0JrI8921hZTk8cBiRQHihhsrgnKKI/xfGkURbgOch+1xiY8LIfLWPuAdZo12k3shH+TxrNtFNkPY8UJrIs931xZSkscDS1IUMWLFAEKyRImVS6wE0igKfrOd/bUirI/IW2uDd5g12kXuOT5EfE6huYifdxZoF9kMwf/CugqtBd59XsjvShkijwdWr6LgeyWSFCsBu0YtiiJUQlYn6kAph/A/Im+tDd5h1mgHubfzhIVtQnbgGWeNVpdNO0dY9/i30Frg/eUFkbcaQGPnGmGJlT/KINzPaC5ULnExhI2dYg2awj6UQ7g/btjx/+NRZIjwuFqOF4oN3l+WaAe5D88blrjTFZoLnnGWaAfZjM9DEVobeb7DtpCWIgt9kpKhiDQJjQI5Kiok950N3nVRIdkUsgJylBdE3jIEI6t4NAjYppG/0Cgk90JRIdkUOhEibylRVEUBqFtcpCSEZgBZKipimadI7jsHvO+iIpZLimRTaAaQpbwg8iYILQrJvVBUSDaFToTIW0pIUQidCMm9UFRINoVOhMhbSkhRCJ0Iyb1QVEg2hU6EyFtKSFEInQjJvVBUSDaFToTIW0pk/cCIROIa5Qqh5+0I7qtZjrw8w6xD8Tl/u76LJCB7WSHOVRWXSklOyyE8Z9HfE3XM04kd2U2KgmxV8PyyRHfpZM7b3SlFLH9dnF+uXnCupCTCzUQRnlse4FnmBZG3GoDgWWdlHVDYcPJ8YXmBe+a+mtGBmaLNsvFybq6RldIuIvKQO95dTCrsfabpPKzDCb9n3WG0Ckx24+fcyshaNrtDJ5tO7E4SYm0nvt96YefKsi0W4bnlBe4zL+R3pQyR9QMLCUySomiXMPO486DRFcXyxvOO6xLXl/OLvDUXPOMkUsG1k7aXA+8uzfHtDjrLsMNEdtvp+bSrTka/dAcJCWXDCFx4v42AczVC3njWcV1iWe6u55Y3spb7ECJvKZGkKNoBNN74ORaJvMV1SaqvyFvzwXtLIhU856Tt5dBu5KRR8O5E3pqDPHVyd5AQ9F6o14pE3pLqkiTL3fHcugN5yn1+V8oQeT6waorCSIWVag2s0vG2LzSVx42Chm37wgZu9eS/bI/3hwjPQbFGxvHsC/fH9xP+r5ICoN6cl1LuXFZPSnifts1KeA77DfiM7zE8Nk3naArTnmN4HWD77fy2LzyewvM3cH228d/wXOE5wu3VwH+yBnWOn5vJQ/y+7T4o1d6fodx2wLZQ9uxZhnLC/iTYs7Z6hOcxWPvifHw3ebT2Ft6f/Q7vMXy38Xu3Ej8jO3dYAOelruF54nuze6LEz6posPvKA/bM7P3FsPdspdxxhlBWKCGszYcI5TGUe2Dywmf8v1rep/3fCnUzGeI+wnOECOWIEspqDPbzjML7iGHbKVbX+Br8P6wPxeS/2nMr145bDdxLXsjvShkizwdmApukAKwBGEwJJB0LKh0fKhw7xq5tgs5nKPQ0HIodZ4WGaw3eGlMMu14Ia1x2Dc4dNsDweLtmuXu1Rm3XN6VkSoVrhXVjH/8xsD+816T6cs7wefI7PCf7YgWSBK7DucM62PX4DPeH5+fewzrbccD+B/i0evIfq5Ndo1akObZe2HuLS9wZVHvWfA+fDeA8Ji8mn/Yfu074PgG/7drVZDq+Zvx87dx2Hupi38Pz2u9wW3h/cT3sOuXaAgiPB5yLbVbfUEYA28PzcazJUxFB/fICz6Xc8+YZh8/R2mS5dxM/9/A9g6Tf4XsM3yHXsGNNJgxp3mdcp1BG7Rx8t3qwLZR7u+dysHNxXsC1wuuF17Frx7If3gv7wuuDpOdm17NzhM+xVcF95IX8rpQh8nxgCGksrAYEMhZAhDgWZEO14+MGD2gA1rD4ZH9cgNXTGgjgd7kGknQtzh8qlLBR2vFxKaeA+F/YeIEdz7nsngzxc47rUu3ZAKtTWOLrlAPXio8N303Sfq6fdE3uweobvg8Q32ca8L+sEd6zgXvn2uF2fsclfD6h7ADOEZ83fkZ8Z5vBnlVcYrkyxNeMZYbvoUwZkjqT+DfntetavWptayDeX6muVp+4xM+vSKB+eaFSG0IG4/fAcyv37Mqdx8D57L1z3lgHhHUpV6+07zPWNfb/8LzsN1mmfvG54+NDsC98RmG9q7XTpLrEsgzC52bnj4vtb2VwH3khvytliDwfWCjYMdgeKwoEMm7ghmrHWyMJETZk9tF4kmD1DPcnXc+QdK1QIYCwUbI9TWPjf/Hxdv7wngymFKy+cV2S6hs+O/t/vUiqU3z/8X72lXu+gOOpEyW8F/5n29M800bur1ZQN7vnENST6yNntTzr8NmB+DeI2xbfw+fJ96S6lEN8jVhmeAf8poTvMpY9EP/mvOG74v/2TpPaXoz4fJXqyvliWSs6rO55IJabEPFzBjzrpOdp7z3pPAb+Z+89SQfEssM75TfF/pf2fcbXSaon+03+uGZ8z5UQ1heE54/lErDd9ifVJek/4XPjWvH+dgHPIi/kd6UMkecDCwU3BttNQA1JgmyodjxCHt9buJ8GUa6RWj1pXAZ+lzs+6VqhQgBx3UKFUg38L75Xrkc9uUZc11gpxHUp92zCOoX/T4tYYYLwHpL2sy++xyRwHuoWvwv+y/bwPishvv8sQF3tnYewd2bPt9qz5t7C89i9huD/bDM54Hv4jGx/rYivmSQzwLbbsSZ74bXj3xwbvmurm5Xw2CTEx1Sqq9UnbB9Fh9U9D9izT5I/tofvCcTPOgTHV3p3tHk7n7WB8L3Yu4rrwn/Yzn/Svs9Y1yRdg/2mN7hWfM+VwLnCe7bnCazeIWw/9UiqC/+Jn2/43MLztxvyvK+2eIJ5PjATvFBYDdaYw4ZQ7lhQ7XhT4LY/bij2/1AJxA0k3BeeK4ZdC5gSCBUCiBslx9v1ANcKjw/B/0IFlHSucD/nCfdbXbgvSlJ9OWd8DTvGENa3Ejgn/7VnHT9P9ofXAnZM+Iz5bvW1egLuzfaFdeJ7eFwlxPeWBahn+B6APfs0z5rv4XlMlsNtHBP+J36WgGvG9Qn/E4LtYR35zjmtnuE+rmPntbqF145/c2x43fBctcDOR+F6nCu8L7ZbPQH74muUu+8iIKx71rB2x2cMa8fxu0w6FvBM2W/tHMTvOfzNseF74Xr2Hiu17TTvk//YsXw3+Qzvgf12bnse4T3zvdw9c2x8j3auau00rIv9h312vG3jnPE1wnOCcH+rgmeRF/K7UobI64EhbFzLSix8AGENjynXYAyVjjcFjlDb/rBBgnCf7bf/hdvC39agQlgjpFjjt2KN0X6bIgn/E24vh/AcSQ01PFdSww63x/UNn0NYj/Cadmy4PX6eBp6RKZj4v/EzDxE/a7tPtof/s+1x3eP7rgSOzwqxDMQlqZ7lnnW4jWLPPJYfeybx9lhew32Uckg6T3h8+Nxte/yfCy+88H9+m1zYb+45/k9YysGeFXUInxvntnpa4fwgvG64vYigfnkgljl+x4ifp8llOcRyYceHz99kFYTHhtev1rZrfZ9hW4z1SyV9k7S9HMJjrX0aYvmOz2X3Ye00vDao5blRDPa7yPJdDuF9ZI38rpQh8nxgecIagZAdTOHEsE66yJBsFAdJckTnE3eEnQLJptAIIKzVSHYRIfKWEiJvQlrYiL0cRN6EWoEsJZG3JCtQp0CyKdQLZKdV206ect8WLawdFQWdAfdlpRVNyK2KcKqDUlQUuW6dhlBerLSi5aBZ4P4FodOQp9y3RQuTohA6EZJ7oaiQbAqdCJG3lJCiEDoRknuhqJBsCp0IkbeUkKIQOhGSe6GokGwKnQiRt5SQohA6EZJ7oaiQbAqdCJG3lJCiEDoRknuhqJBsCp0IkbeU6A5FQURiu6cCIFVGUgoEg6UysUhYS+bYqbmt8kZ3yD3XrCQTQusA/VUteWu96A7ZbAW0evon2n67t3/aRL1povJ8t23RwvJuDJZKop3Jm2XFrrWhGnGjiLzlg7zl3t6vyFvrA93FuxR5yw9G3Fr12WRJ9osC69tF3nJCHg+MDivM28RL7nTLWwxZ3vJFd3QCXFPkrTWBzgrzRcrylj3oM8L20qqWN+6h3YmbgfsUecsJWT8wIyUib5Uh8pYvuqMT4Joib60HdBfvTuQtX8Q6tBXJm+n1UHbaGSJvOSLLB2ZKz4q9VCNv4f64U2O/7aumJMNjQ1IYXz/cZ4rAGle8PwR1s2P4Hp7X7incBkzxhP/lGINtNySRt7Bu8f+FxhA++6wQvj9733yG+0L5MITyHCtC9tEewv+FMmNyxzG2P5Yb2x7/187NOeJ9SYjrHrYBuybHcL7wWYTtOf5PeE2+2z4K5wCVnp39pti57H4o/Dd8NpwD2LawbiCug+kIe1bh/rDuILyuXacWcHzWCN9xfM9W57je5eTDnh3Fnk/4bvgevmf+D8JtMWy7Fd6bPetwv13PEF7XrlMO4bGUEOH2cJ/JHnUP3285cI2wjvZ/K5wH2DMM30V4/vActo1zA/bFx8TgXBwf3rNd22DbKbEsV9pn1+caJh/1gHPkhfyulCGyfmChsBtMUE3YEKjwhbM9PJ5jTVBjcKwJvF3LhMsEFnA+q4cpAYpd1/aXu47tD8HvUJCTGp6dL6wn29gXni+uO7/DZ2J1ZrvQOMJnnwViubd3zqfto1gbMPA7lEFkwOSAffY/O8baksmL7Tc5sv8Ywu9hmwjPnUbGTC4N4X2Hcm73EMtxKONst3rH56V+lErPLjw+vDfAcwrbZ1K9w+cews4VPhd7XnZOPsP6cF92vNXZ7q0awnplAe7T6hLXO6ynPSPqb/drvw38P7wv7tueiT23EOH5gR2bBM4VvhOrj50zfi8cGx5PncN7C8FxoeyF9U56Jhxv79GKXZfv5a7D9qR7jO+Nc4XHsT98TvE14v/HdQ7BsVZn+w/HhsezzxC3nUr7wvuz58P16kF4nayR35UyRNYPzF6ovWwQC5o1ShA3ECtJgmmCVA1ho7d6hNc0UK9KgsfxlRpU2JiqNS72hde3+7bz2/64hNcX6gfPMkvwvk2pGbimyURSu0iS51guQmVpCM8by134fwrf42LHJ527Guychvi+OHfYpuweOQ6wL+mabC8n60nPrtq9xfW033YNPq1OMeI6g/hZhfdpx8el1mfLsVmCuiZdg+2hjopRTvbiEr5vftszBvwOr2HvJwmcJ9wfv8NYDjie33FJAttD+UmCnZ9i9agke0nyE9+DIb4XjrH/sy98hsBkKrzX8Ly8l0rvrtLxVpe4cHylfVanEJw3rnutiM+VJfK7UobI+oElCXssaKEgc1ytLz9uADFsP9eL65H0XwSy0rVjgbdzcG6+h/dYrXGxL7y+1Y/zAI4P/y80F/G7bzZ417zDEFzT3mlSu0iSSRD+L+m8oazFcgf4P+dme/zfEEnnroa4zvF9cc2wTbGd/RwH7P9WDHy3thAj6dlVuzcQntOOtzZZ6b9xnUH8rML75Bp23noQPoeswDWs2DMJn0cS4nu291AJ4Tm5DoX/8F++h+8wRizL9l9DLAd23mqI/xfD9tv7DOuR9N8k+TDE9xAi3FdOlgx2XXtX8XmrvbtKx7M9vH6ISvvi9wE4Nq57rYjPlSXyu1KGyPqBJQl7LGihENjxSQ0hRqVGE183/l1O8Co1gPB6JtDWKMKGAao1LvaF17f6WeNkf6W6CI0hfvfNBu8ufn9c02QilkdgMhluA6FccE6TPUO4P5a78DocU0mxJp27GqzOhvi+qEt4zbANhbDtdmx8HyHKPbtK9wasDdqzCOtS7logqc7xswrv046vF438Ny2osz3L+F3FKCd7/Lccwmdn/7V3W+mZAzvOUE3WOJ5jagH/K3dsfN3wdznZC+sVolKbsv9xrrAuXIvtobwl3WtYR5Ptcqh0PNdmfxKq7YvryXnLHV8N5Z5hFsjvShki6wcWCp0JTyxoJgQG9sUCUK4BcFzSsXZdaxR2DRN++23748ZRDlyL89tx3JNtC8G2So2LfeE9x/W13+E5uKbtFxpD+OyzQCxf9tveaTl5Q27CuvG/UL6RoXC/yZ+B7+HvWO74byir1MNkjONiOa4Guy/OA/g/vyncW1w/toXHx/vsN/+zcxisbuWeHdvK3Ruwa4fb7HnF5wph/6v0rOL75Hv43EGtz5ZrZQnqanIJ7P7tuYb1ZLsdmyQf/I7rGx/D+dlmz9ieVXxcDI7hWP5n9QivFcsBx/Kb7YZy17B6Jx0b1s2uwbnD3+F5rZ5JYHssByH4L+eLwTb2GeLzJNWRUu5acR35b3hsfE+c046vti8+DyWse63gf3khvytliDwemAmoCWD4gtlmvykIRvifeHsS4mMNCJxtC7+jBEwRxNurgeNDwbSGYwoE2PkoHF/LPYe/rR6cM9xermEK6cHzzBrhezY5Y1v8XmO5C+U5lDWADIQySwnB8eH++P+xrNn+8JqhnJnsVmob4X/tnrnHuJ7W5qxwTLn2D+J9/L/Ssyt3byHYznkNfE86Loadk+vFz6rc+wi3hdurIc2x9YB7DuscPo/4GZoslJMPYDJihXcUgmuFz9iuER8Xw+rI+ZNkIf4d/ifenoT4WKtPeG7qbffH8Vb38L98Lwc7ns8kcK3w+Yew81PiZx7XkTrExxjC89hx4X9B/N6T3lct+zh/uD8N+H9eyO9KGSLPB1YkmPALnYlWffco3kqdBYqzXGfQCLI4p5AM6aXiwshKNeIZgrZTrs2yrxyx6zTkKfdt0cI6VVGIvHU2WvXd503ebJQu5Ac97+KiHvIGzOIVI2lbpyJPuW+LFtaJioLOjfu2opFP56EV5R5iZjKbpPRtH6USwROKDd6fUDxA2MI2hgEgDWyK1AZEes//izyfR1s8eQmQ0ImQ3AtFhWRT6ESIvKWEFIXQiZDcC0WFZFPoRIi8pYQUhdCJkNwLRYVkU+hEiLylhBSF0ImQ3AtFhWRT6ESIvKWEFEV9sGjVLIMdOH8zIweF/0JyXzuQwXpzN9UCCyASpkHPonEgrwpEay3kKfdt0cKkKIROhOS+NhixypK8Cf8LyWZzwHNMGxEqdB/ylHuRNyFXoIikjJoDyX15xHLWbMubcltVRivIJjKRNtdZd4BnKQtca0DkLSXUibUOeFcib82B5L48YjlrJnlrNhFsRxRdNutNVNsdQI41WGgN5Cn3Im9VECY1tIZuv1HiIFQE5ZIXouzZRkOMk4/a8RQ7J+A//LZ9dn3+b9usUYfH8T2st3U04TZg/zFQN/ttx8VKI7w/K+U6MnsunNe+h0VoDHk8w1BmKCaDIJaFcJ/Jbiir4f4kWBuhxHLHNms7dkySNaKcnFEXzh/uj9thUruKER5D4by2PWwH/OYc1qbCYzsB3G+WsPeITIVyGCKWBXv+sUyX01+cl/fI/+xY3qfB9pvc2r7w+Pjctp068F9DeI5wO7D74FMoNnhPeSG/K2WIrB9YqCgMNDYaaawg7Bi+m7Lg0xq2KXUDx9k+PvnNOa0xU0LwfzsecJw1dlNKIcLzAzs2VDDArh1us/PZPfHfUBnxPbyXEOFzCa8f/xbqh72nrGDv3zqN8P2bvBiQA5OFUHbtXbOvUn35Tywndj47V3g+jjdZTkJ4LDB5L1d/zhUeX+n8nMvOAzguPLf9ptg57PrWltod4bNtNmrRuXaMya7Jcry/3PsweQ3/Y++V/4b77RqAY+14wHEmx/zfrse2UDZM9thmx4dAtkL5FIoJ5CEv5HelDJH1A0tq6DSmSoog3M9nUh3ZntRQDeE5DJwnLtZpAH6HjZzf4TXC88X1iju0+L5ChQP4f3jtGPb/uD5SQs1B+K6yAO87lr8kIAPUJZSzWHaTZMHAtliOkDmON9mL/xvLYoz4+FhW7fzUC/A9LuVkO0nuqUu4LakTZn+lOrcTeH5ZoprO5TnHz5p9Vq+k/8dIkjH+Y9dI2k8dOCYugGNjuQFhvcohvDehuKj2HpuJ/K6UIbJ+YNUURbX9gP1WrFOhMccKPkR8DrtOJYTn5DoU/sN/+R7WMVYadqwhvq94f5LyCmH/53+G+LdQP8J3kQWqdRjspw6851iWk/5b7t1zHMeHiGUn/m812YuPj6+BTFvd7Vq1Iqm+1CXcFj8PUK3O7YQ0z7Me2Dsrp3OTnjXyEL/z8P8xks5R7Rp2/iTYNa2E1w63J7WR8LpCccH7ywv5XSlDZP3AqimKavtDsN2OZT+/yyHpHPF1YrCPY6iTKRY7T3wufnOswZSbIem+UFhso1SqO7D/h8oo/i3UD55llqhENtjOfkP8O5bdJFkymBxyjCE+PpabSnUD8fFcI5TXsJ2A8FrVEJ8LUJdwW/w8QPxM2hk8zyyRJE/h8+XZx+8o1G+V5NGQJGP8x+QqaT/XrEW/cR5KKPOA/yfVq9bzCt0L3l1eyO9KGSLrB2YN3RqPKQEKyqKaIuEzbHjs41j7X6gA2G7HhucwcCz/CZGkQNhm9eEcti0E28Nz2X0Z4vuK76Ma4ucG7DeF/UL9CN9VFjB5CN8fMsB7Q5aQKQPfQ7LC73A/x8dkJgTXCY/nOuHxcT2SOs4QsZxZGzAg0xxjMsi5+B2i3PnDc/EdxM/Dzmfnt2fZKcj6XnmuXMN0E+D52/uw9xu+Q2TG9of/t20xOD68j/C9gyQZ5Bj+Y+8d2DF8hvW14/hPKNtcIzzO6hqeUygmQnnJGm2hTfJ4YKaMKXw3RWFKwoopaSscy3Hh//ltsIZpxTqscBv/DWFKxUrY0IHVz2DXCI8zJWMl/h3fB7/DewhLeD+G+L5MOVnd7Z5iBSnUjjyeWywH9q7j92uyYXLHZygvoTyWgx1LsXYQX4frc674uBihnMVyG9+TtQv7T7w9RtjmqV/SfbKN84V15ViDXatdkeW9hc+fEr9Pnn3ScbGesneTpL8A7yiWHUMlGUySN8B1QhkLt4f/ievDceE17NhQnoRigPeSF9pCe+T5wDoZ5ZRcue1Ctiiy3NO5dbJc0MHGnXonoR10spG37gZtqdxAQigWRN5SQuQte9goNgbbRd66ByJvxYXIW+vr5CKQN56jWeiE4iNPuW8L1tMOiqIVQGfMsw5LJ3dQ3Y2iyn0oH0WwXOQN2oTdPyS2E8G9tzIqTYvmBeqgqdHWQp5y3zbkTUVFRUVFRUWlO0teaAvyJgiCIAiC0CkQeRMEQRAEQWghiLwJgiAIgiC0EETeBEEQBEEQWggib4IgCIIgCC0EkTdBEARBEIQWgsibIAiCIAhCC0HkTRAEQRAEoYUg8iYIgiAIgtBCEHkTBEEQBEFoIYi8CYIgCIIgtBBE3gRBEARBEFoIIm+CIAiCIAgtBJE3QRAEQRCEloFz/x9rQ/PRT6OfuwAAAABJRU5ErkJggg==" /></p><p><em>Dibasa 25,000 I.U./2.5 mL oral solution</em></p><p><em>Neonates, children and adolescents (&lt;18 years) Prevention: the recommended dose is 1 single dose container (equal to 25,000 I.U. of vitamin D3) every 1-2 months.</em></p><p><em>Treatment: the recommended dose is 1 single dose container (equal to 25,000 I.U. of vitamin D3) once a week for 8-12 weeks, followed by the maintenance therapy, which will be assessed by your doctor based on your health condition.</em></p><p><em>&nbsp;</em></p><p><em>Adults and the elderly</em></p><p><em>Prevention: the recommended dose is 1 single dose container (equal to 25,000 I.U. of vitamin D3) once a month.</em></p><p><em>In case of a high risk of deficiency, the doctor will assess whether you need to increase the dose to 2 single dose containers (equal to 50,000 I.U. of vitamin D3) once a month.</em></p><p><em>Treatment: the recommended dose is 2 single dose containers (equal to 50,000 I.U. of vitamin D3) once a week for 6-8 weeks, followed by the maintenance therapy, which will be assessed by your doctor based on your health condition. Dibasa 50,000 I.U./2.5 mL oral solution</em></p><p><em>&nbsp;</em></p><p><em>Neonates, children and adolescents (&lt;18 years)</em></p><p><em>Prevention: the recommended dose is 1 single dose container (equal to 50,000 I.U. of vitamin D3) every 2-4 months.</em></p><p><em>Treatment: the recommended dose is 1 single dose container (equal to 50,000 I.U. of vitamin D3) once a week for 4-6 weeks, followed by the maintenance therapy, which will be assessed by your doctor based on your health condition.</em></p><p><em>&nbsp;</em></p><p><em>Adults and the elderly</em></p><p><em>Prevention: the recommended dose is 1 single dose container (equal to 50,000 I.U. of vitamin D3) every 2 months.</em></p><p><em>In case of a high risk of deficiency, the doctor will assess whether you need to increase the dose to 1 single dose</em></p><p><em>container (equal to 50,000 I.U. of vitamin D3) once a month.</em></p><p><em>Treatment: the recommended dose is 1 single dose container (equal to 50,000 I.U. of vitamin D3 once a week for 6-8 weeks, followed by the maintenance therapy, which will be assessed by your doctor based on your health condition.</em></p><p><em>If you take more Dibasa than you should</em></p><p><em>In case of accidental ingestion/intake of an overdose of Dibasa, immediately inform the doctor or visit the closest hospital. In case of overdose, there might be an increase in the levels of calcium in blood and urine, with the following symptoms:</em></p><p><em>nausea, vomiting, thirst, intense thirst (polydipsia), increased quantity of urine excreted (polyuria), constipation and dehydration.</em></p><p><em>&nbsp;</em></p><p><em>Chronic overdose can cause build-up of calcium salts in blood vessels and organs.</em></p><p><em>The use of an excessive dose of vitamin D during the first 6 months of pregnancy can cause serious harm to the foetus and to the neonate.</em></p><p><em>If you forget to take Dibasa</em></p><p><em>Do not take a double dose to make up for the forgotten dose.</em></p><p><em>If you stop taking Dibasa</em></p><p><em>If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</em></p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>&nbsp;</strong></p><p><em>Like all medicines, this medicine can cause side effects, although not everybody gets them.</em></p><p><em>The side effects reported with the use of vitamin D are listed below:</em></p><p><em>- allergic reactions;</em></p><p><em>- weakness, loss of appetite (anorexia), thirst;</em></p><p><em>- drowsiness, confusion;</em></p><p><em>- headache;</em></p><p><em>- constipation, emission of gas (flatulence), stomach pain, nausea, vomiting, diarrhoea, metallic taste, dry mouth;</em></p><p><em>- rash, pruritus;</em></p><p><em>- excessive build-up of calcium in the kidneys (nephrocalcinosis), increased quantity of urine excreted (polyuria), intense thirst (polydipsia), kidney disease (renal insufficiency)</em></p><p><em>- high calcium levels in blood (hypercalcaemia) and in urine (hypercalciuria).</em></p><p><em>&nbsp;</em></p><p><em>Reporting of side effects</em></p><p><em>If you get any side effects, talk to your doctor, or pharmacist. This includes any possible side effects not listed in this leaflet. By reporting side effects, you can help provide more information on the safety of this medicine.</em></p><p><em>&nbsp;</em></p><p><em>To report any side effect(s):</em></p><p><em>&bull; Saudi Arabia:</em></p><p><em>The National Pharmacovigilance and Drug Safety Centre (NPC)</em></p><p><em>o Fax: 7662-205-11-966+</em></p><p><em>o Call NPC at 2038222-11-966+,</em></p><p><em>Exts: 2317-2356-2340.</em></p><p><em>o SFDA Call Center: 19999</em></p><p><em>o E-mail: npc.drug@sfda.gov.sa</em></p><p><em>o Website: www.sfda.gov.sa/npc</em></p><p><em>&nbsp;</em></p><p><em>&bull; Other GCC States:</em></p><p><em>- Please contact the relevant competent authority.</em></p><p><em>&nbsp;</em></p><p><em>This is a Medicament</em></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>A Medicament is a product, which affects your health, and its consumption, contrary to instruction, is</em></p><p><em>dangerous for you.</em></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Follow strictly the doctor&rsquo;s prescription, the method of use and the instructions of the pharmacist who sold the medicament.</em></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>The doctor and the pharmacist are experts in medicine, its benefits and risks.</em></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Do not, by yourself, interrupt the period of treatment prescribed for you.</em></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Do not repeat the same prescription without consulting your doctor.</em></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Keep medicaments out of the reach of children.</em></p><p><em>&nbsp;</em></p><p><em>&nbsp;</em></p><p><em>Council of Arab Health Ministers</em></p><p><em>Union of Arab Pharmacists</em></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><em>Keep this medicine out of the sight and reach of children.</em></p><p><em>Do not use this medicine after the expiry date which is stated on the carton after &ldquo;EXP&rdquo;. The expiry date refers to</em></p><p><em>the last day of that month.</em></p><p><em>&nbsp;</em></p><p><em>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</em></p><p><em>&nbsp;</em></p><p><em>Do not store above 30&deg;C. Do not freeze.</em></p><p><em>Store in the original package in order to protect from light.</em></p><p><em>Dibasa 10,000 I.U./mL oral drops, solution The shelf-life of the medicine after the bottle is opened is 5 months (note the date of first opening in the dedicated section of the carton).</em></p><p><em>After this period has elapsed, the residual medicine must be eliminated.</em></p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><em>Dibasa 10,000 I.U./mL oral drops, solution</em></p><p><em>- The active substance is cholecalciferol (vitamin D3) 2.5 mg equal to 100,000 I.U. 1 drop contains: 250 I.U. of vitamin D3.</em></p><p><em>- The other ingredient is refined olive oil. Dibasa 25,000 I.U./2.5 mL oral solution In one single dose container:</em></p><p><em>- The active substance is cholecalciferol (vitamin D3) 0.625 mg equal to 25,000 I.U.</em></p><p><em>- The other ingredient is refined olive oil.</em></p><p><em>Dibasa 50,000 I.U./2.5 mL oral solution</em></p><p><em>In one single dose container:</em></p><p><em>- The active substance is cholecalciferol (vitamin D3) 1.25 mg equal to 50,000 I.U.</em></p><p><em>- The other ingredient is refined olive oil.</em></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Oral drops, solution.
Dibasa presents as a solution that is contained in an amber-coloured glass bottle, closed with a child-proof
polypropylene cap.
It is available in the pack with 1 bottle, 10 mL, and 1 dropper.
Oral solution: Dibasa presents as a solution contained in an amber-coloured glass container, closed with a polypropylene cap.
It is available in packages with 1, 2 or 4 single dose containers, 2.5 mL each.
Not all pack sizes may be marketed.


            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><em>ABIOGEN PHARMA S.p.A. - Via Meucci, 36 &ndash; Ospedaletto &ndash;</em></p><p><em>Pisa, Italy</em></p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                 05/2022
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">يحتوي ديبازا على كوليكالسيفيرول، والذي يعرف باسم فيتامين &quot;د<sub>3</sub>&quot;.</p><p dir="RTL">يستخدم ديبازا للوقاية من نقص فيتامين &quot;د&quot; وعلاجه.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">- إذا كنت تعاني من حساسية تجاه كوليكالسيفيرول (فيتامين &quot; د<sub>3</sub>&quot;) أو تجاه أي مكون من المكونات الأخرى بهذا الدواء المدرجة في قسم (6).</p><p dir="RTL">- إذا كانت مستويات الكالسيوم في الدم لديك مرتفعة فرط كالسيوم الدم) أو في البول (فرط كالسيوم البول).</p><p dir="RTL">- إذا كنت تعاني من حصوات بالكلى تحصي الكلية أو ترسب الكالسيوم في الكلى (كلاس كُلوي).</p><p dir="RTL">- إذا كان لديك مرض بالكلى (قصور) كلوي) (انظر قسم: &quot;تحذيرات واحتياطات).</p><p dir="RTL"><strong>تحذيرات واحتياطات</strong></p><p dir="RTL">تحدث إلى طبيبك أو الصيدلي الخاص بك قبل تناول ديبازا.</p><p dir="RTL">قد يوصي الطبيب بتناول ديبازا للوقاية من نقص<strong> </strong><strong>فيتامين &quot;د&quot; في الحالات الآتية:</strong></p><p dir="RTL">- للأطفال حديثي الولادة وخاصة الأطفال المبتسرين والرضع.</p><p dir="RTL">- أثناء الثلث الأخير من الحمل.</p><p dir="RTL">- للسيدات المرضعات، وفي آخر الشتاء وفي فصل الربيع.</p><p dir="RTL">- للمرضى من كبار السن.</p><p dir="RTL">- في حالة التعرض غير الكافي لضوء الشمس، وخاصة في الأطفال والمراهقين.</p><p dir="RTL">- في حالة اتباع نظام غذائي غير متوازن على سبيل المثال ضعيف الكالسيوم، النظام الغذائي النباتي.</p><p dir="RTL">- &nbsp;في حالة تلون الجلد الشديد.</p><p dir="RTL">- في حالة الإصابة بأمراض جلدية واسعة النطاق، أو أمراض معدية (على سبيل المثال: مرض السل الجذام، أو أمراض هضمية أو أمراض كبدية قصور كبدي).</p><p dir="RTL">- في المرضى الذين يخضعون للعلاج بمضادات الصرع أو يخضعون لعلاج طويل الأمد ببعض الأدوية المضادة للالتهابات.</p><p dir="RTL"><strong>قد يصف لك الطبيب اختبارات منتظمة للتحقق من مستويات فيتامين &quot;د&quot; أو الكالسيوم في الدم والبول في الحالات الآتية:</strong></p><p dir="RTL">- إذا كنت بحاجة إلى تناول ديبازا لفترة طويلة وبجرعات مرتفعة.</p><p dir="RTL">- إذا كنت من كبار السن وتخضع بالفعل للعلاج بأدوية بعض أمراض القلب (جليكوزيدات القلب أو بالأدوية الخافضة لضغط الدم عن طريق زيادة إفراز البول مدرات البول.</p><p dir="RTL">- إذا كنت تعاني من الساركويد، وهو عبارة عن مرض التهابي من الممكن أن يصيب الجسم بالكامل ويؤدي إلى تشكيل عقيدات. إذا كانت مستويات فيتامين &quot;د&quot; أو الكالسيوم مرتفعة لديك، سيقوم طبيبك بخفض الجرعة أو إيقاف العلاج بديبازا.</p><p dir="RTL">بصفة عامة، يجب عليك عدم تناول ديبازا إذا كان لديك قصورا بوظائف الكلى انظر قسم لا تتناول ديبازا في الحالات الآتية&quot; ولكن إذا كان الطبيب يعتبر أن العلاج بديبازا ضرورة حتمية، ستكون بحاجة إلى أداء اختبار للتحقق من مستويات الكالسيوم والفوسفات بالدم. إذا كانت مستويات الكالسيوم والفوسفات مرتفعة لديك، سيقوم طبيبك بخفض الجرعة أو إيقاف العلاج بديبازا.</p><p dir="RTL">قم بإبلاغ الطبيب في الحالات الآتية؛ لأنه قد يكون من الضروري زيادة الجرعات، مقارنة بالحالات المشار إليها في القسم : 3 كيفية تناول ديبازا&quot;:</p><p dir="RTL">- إذا كنت تتناول أدوية تستخدم لعلاج نوبات التشنج (مضادات الاختلاج أو الباربيتورات) (انظر) قسم تناول ديبازا مع أدوية أخرى.</p><p dir="RTL">- إذا كنت تتناول الكورتيزون، وهي أدوية تستخدم لعلاج الالتهاب (انظر قسم تناول ديبازا مع أدوية أخرى.</p><p dir="RTL">- إذا كان لديك مرض هضمي سوء امتصاص بالأمعاء، أو تَلَيُّفُ البنكرياس الكيسي أو التليف الكيسي).</p><p dir="RTL">- إذا كنت تعاني من مرض كبدي (قصور) كبدي).</p><p dir="RTL">- إذا كنت تتناول أدوية تستخدم لخفض نسبة الأحماض الدهنية بالدم مثل كوليستيبول، وكولستيرامين، وأورليستات (انظر قسم: تناول ديبازا مع أدوية أخرى&quot;.</p><p dir="RTL">- إذا كنت تتناول مضادات الحموضة المحتوية على الألومنيوم، والأدوية التي تستخدم لعلاج الزيادة المفرطة في الحمض بالمعدة، والتي من الممكن أن تدخل المريء انظر قسم: تناول ديبازا مع أدوية أخرى.</p><p dir="RTL">- إذا كنت تعاني من السمنة.</p><p dir="RTL">- تناول ديبازا مع أدوية أخرى</p><p dir="RTL">يُرجى إبلاغ الطبيب أو الصيدلي الخاص بك إذا كنت تتناول أو تناولت مؤخرًا أو قد تتناول أية أدوية أخرى.</p><p dir="RTL">على وجه الخصوص، أخبر طبيبك إذا كنت تتناول الأدوية الآتية؛ لأنها قد تخفض من تأثير ديبازا</p><p dir="RTL">- &nbsp;الأدوية التي تستخدم لعلاج نوبات التشنج (مضادات الاختلاج أو الباربيتورات).</p><p dir="RTL">- &nbsp;إذا كنت تتناول أدوية تستخدم لخفض نسبة الأحماض الدهنية في الدم مثل كوليستيبول، وكولستيرامين، وأورليستات.</p><p dir="RTL">- إذا كنت تتناول مضادات الحموضة التي تحتوي على الألومنيوم، والأدوية التي تستخدم لعلاج الزيادة المفرطة للحمض في المعدة، والتي من الممكن أن تصعد إلى المريء.</p><p dir="RTL">- الكورتيزون، وهي أدوية تستخدم لعلاج الالتهاب.</p><p dir="RTL">علاوة على ذلك، إذا كنت تتناول الأدوية الآتية، قم بإبلاغ الطبيب، الذي سيراقب حالتك وسيقوم بالتقييم بعناية سواء إذا كنت بحاجة إلى إجراء اختبارات إضافية أم لا:</p><p dir="RTL">- مدرات البول من الثيازيدات، أدوية تستخدم لعلاج ارتفاع ضغط الدم عن طريق زيادة إفراز البول.</p><p dir="RTL">- &nbsp;المستحضرات التي تحتوي على الماغنسيوم.</p><p dir="RTL">- &nbsp;أدوية الديجيتالس التي تستخدم لعلاج بعض أمراض القلب.</p><p dir="RTL">- وارفارين، وهو دواء يستخدم لزيادة سيولة الدم.</p><p dir="RTL"><strong>تناول ديبازا مع الأطعمة والمشروبات والكحوليات</strong></p><p dir="RTL">أخبر طبيبك إذا كنت تتناول منتجات أخرى تحتوي بالفعل على فيتامين &quot;د&quot;. أو الأطعمة الغنية بفيتامين &quot;د&quot; أو إذا كنت تستخدم الحليب المدعم بفيتامين د&quot; حتى يتمكن من النظر في الجرعة الكلية التي تتناولها من فيتامين &quot;د&quot;</p><p dir="RTL">لتجنب الجرعة الزائدة (أنظر القسم تحذيرات واحتياطات&quot;).</p><p dir="RTL">تناول كميات مرتفعة من الكحوليات لفترة طويلة للغاية إدمان الكحول المزمن يقلل من احتياطي فيتامين &quot;د&quot; في الكبد.</p><p dir="RTL"><strong>الحمل والرضاعة الطبيعية</strong></p><p dir="RTL">إذا كنت حاملاً أو مرضعا، أو تعتقدين أنك حامل أو تخططين للحمل فاستشيري طبيبك أو الصيدلي الخاص بك قبل استخدام هذا الدواء.</p><p dir="RTL"><strong><u>الحمل</u></strong></p><p dir="RTL">أثناء الأشهر الستة الأولى من الحمل، سيصف الطبيب هذا الدواء فقط إذا رأى أن هناك ضرورة ملحة، وذلك بسبب خطورة الآثار الضارة على الجنين.</p><p dir="RTL">(انظر قسم: 3 &quot;إذا تناولت كمية أكثر مما يجب من ديبازا&quot; )</p><p dir="RTL"><strong><u>الرضاعة الطبيعية</u></strong></p><p dir="RTL">سيصف الطبيب هذا الدواء أثناء الرضاعة الطبيعية، عند الضرورة. وهذا لا يعد بديلا عن إعطاء فيتامين &quot;د&quot; لحديثي الولادة.</p><p dir="RTL"><strong>القيادة واستخدام الآلات</strong></p><p dir="RTL">من غير المحتمل أن يكون لديبازا أي تأثير في القدرة على قيادة المركبات.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">تناول دائما هذا الدواء بالضبط كما أخبرك الطبيب أو الصيدلي الخاص بك.</p><p dir="RTL">راجع طبيبك أو الصيدلي الخاص بك إذا لم تكن متأكدا من كيفية التناول.</p><p dir="RTL">سيتم تقييم الجرعات ومدة العلاج من قبل الطبيب، استنادا إلى حالتك</p><p dir="RTL">الصحية. لا تتجاوز الجرعات المشار إليها من قبل الطبيب.</p><p dir="RTL">يجب تناول الجرعات عن طريق الفم. يوصى بتناول ديبازا مع الوجبات.</p><p dir="RTL"><strong><u>ديبازا </u></strong><strong><u>10,000</u></strong><strong><u> وحدة دولية / ملل قطرات عن طريق الفم، محلول</u></strong></p><p dir="RTL">يمكن تناول الجرعات اليومية الموصى بها أدناه مرة واحدة في الأسبوع عن</p><p dir="RTL">طريق مضاعفة الجرعات اليومية الموصى بها بسبع مرات.</p><p dir="RTL"><strong><u>حديثو الولادة، والأطفال والمراهقون أقل من </u></strong><strong><u>18</u></strong><strong><u> عامًا)</u></strong></p><p dir="RTL">للوقاية الجرعة الموصى بها هي 2-4 قطرات في اليوم بما يُساوي 1,000-500</p><p dir="RTL">وحدة دولية من فيتامين &quot; د<sub>3</sub>&quot;).</p><p dir="RTL">للعلاج الجرعة الموصى بها هي 16-8 قطرات في اليوم بما يساوي 4,000-2,000</p><p dir="RTL">وحدة دولية من فيتامين &quot; د<sub>3</sub>&quot;) لمدة 5-4 أشهر.</p><p dir="RTL"><strong><u>السيدات الحوامل</u></strong></p><p dir="RTL">الجرعة الموصى بها هي 3-2 قطرات في اليوم بما يُساوي 750-500 وحدة دولية من فيتامين &quot; د<sub>3</sub>&quot; أثناء الثلث الأخير من الحمل.</p><p dir="RTL"><strong><u>البالغون والمرضى من كبار السن</u></strong></p><p dir="RTL">للوقاية: الجرعة الموصى بها هي 4-3 قطرات في اليوم بما يساوي 1.000-750 وحدة دولية من فيتامين &quot; د<sub>3</sub>&quot;). في حال وجود خطورة مرتفعة لحدوث نقص سيقيم الطبيب ما إذا كنت بحاجة إلى زيادة الجرعة إلى 8 قطرات في اليوم بما يساوي 2,000 وحدة دولية من فيتامين &quot; د<sub>3</sub>&quot;).</p><p dir="RTL">للعلاج الجرعة الموصى بها هي 30-20 قطرة في اليوم بما يُساوي 7.500-5,000وحدة دولية من فيتامين &quot; د<sub>3</sub>&quot; لمدة شهرين، يتبعها علاج المداومة، والذي سيُقيم من قبل طبيبك استنادا إلى حالتك الصحية.</p><p dir="RTL"><strong>تعليمات الاستخدام</strong></p><p dir="RTL">تحتوي العبوة على زجاجة واحدة وقطارة واحدة للزجاجة غطاء مقاوم لعبث الأطفال، وللقطارة غطاء اتبع تعليمات الاستخدام الواردة أدناه:</p><p dir="RTL">أ. افتح الزجاجة عن طريق إزالة الغطاء على النحو الموصوف أدناه: اضغط على الغطاء أثناء فكه (انظر الشكل (1).</p><p dir="RTL">ب. قم بفك الغطاء البلاستيكي الذي يغطي طرف القطارة (انظر الشكل 2).</p><p dir="RTL">ج. ادخل القطارة في الزجاجة لجمع المحتوى؛ قم بمعايرة عدد القطرات الموضحة من قبل الطبيب في ملعقة صغيرة وقم بتناولها.</p><p dir="RTL">د. اغلق الزجاجة انظر الشكل (3) ؛ أدر الغطاء على القطارة مرة أخرى.</p><p dir="RTL">ه- ضع الزجاجة والقطارة فى العبوة مرة اخرة .</p><p dir="RTL">&nbsp;</p><p dir="RTL"><img src="data:image/png;base64,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" alt="" width="278" height="118" vspace="0" hspace="0" border="0" style="width:278px;height:118px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" /></p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong><u>ديبازا </u></strong><strong><u>25,000</u></strong><strong><u> وحدة دولية /</u></strong><strong><u>2,5</u></strong><strong><u> ملل محلول عن طريق الفم </u></strong></p><p dir="RTL"><u>حديثو الولادة والأطفال والمراهقون أقل من </u><u>18</u><u> عاما)</u></p><p dir="RTL"><u>للوقاية:</u> الجرعة الموصى بها هي عبوة واحدة تحتوي على جرعة واحدة (بما يساوي 25,000 وحدة دولية من فيتامين &quot; د<sub>3</sub> &quot; كل شهر إلى شهرين.</p><p dir="RTL"><u>للعلاج</u> :الجرعة الموصى بها هي عبوة واحدة تحتوي على جرعة واحدة (بما يساوي 25,000 وحدة دولية من فيتامين &quot; د<sub>3</sub>&quot; مرة واحدة في الأسبوع لمدة 12-8 أسبوعًا، يتبعها علاج المداومة، والذي سيقيم من قبل طبيبك استنادا إلى حالتك الصحية.</p><p dir="RTL"><strong><u>البالغون والمرضى من كبار السن</u></strong></p><p dir="RTL"><u>للوقاية:</u> الجرعة الموصى بها هي عبوة واحدة بحجم جرعة واحدة بما يُساوي 25,000 وحدة دولية من فيتامين &quot;&nbsp;د<sub>3</sub>&quot; مرة واحدة كل شهر. في حال وجود خطورة مرتفعة لحدوث نقص، سيقُيَّم الطبيب ما إذا كنت بحاجة إلى زيادة الجرعة إلى عبوتين بحجم جرعتين ( بما يساوي 50,000 وحدة دولية من فيتامين &quot; د<sub>3</sub>&quot;) مرة واحدة في الشهر.</p><p dir="RTL"><u>للعلاج</u> : الجرعة الموصى بها هي عبوتين بحجم جرعتين بما يساوي 50,000 وحدة دولية من فيتامين &quot; د<sub>3</sub>&quot; مرة واحدة في الأسبوع لمدة 8-6 أسبوعا، يتبعها علاج المداومة، والذي سيقُيَّم من قِبَل طبيبك استنادا إلى حالتك الصحية.</p><p dir="RTL"><strong><u>ديبازا </u></strong><strong><u>50,000</u></strong><strong><u> وحدة دولية / </u></strong><strong><u>2,5</u></strong><strong><u> ملل محلول عن طريق الفم</u></strong></p><p dir="RTL"><u>حديثو الولادة والأطفال والمراهقون (أقل من </u><u>18</u><u> عاماً)</u></p><p dir="RTL"><u>للوقاية</u>: الجرعة الموصى بها هي عبوة واحدة بحجم جرعة واحدة بما يساوي 50,000 وحدة دولية من فيتامين &quot; د<sub>3</sub>&quot;) كل 4-2 أشهر.</p><p dir="RTL">للعلاج الجرعة الموصى بها هي عبوة واحدة بحجم جرعة واحدة (بما يساوي 50,000 وحدة دولية من فيتامين &quot; د<sub>3</sub>&quot;&quot;)</p><p dir="RTL">مرة واحدة في الأسبوع لمدة 6-4 أسبوعا، يتبعها علاج المداومة، والذي سيُقيَّم من قِبَل طبيبك استنادا إلى حالتك الصحية.</p><p dir="RTL"><u>البالغون والمرضى من كبار السن</u></p><p dir="RTL"><u>للوقاية</u> : الجرعة الموصى بها هي عبوة واحدة بحجم جرعة واحدة بما يساوي 50.000 وحدة دولية من فيتامين &quot;&nbsp;د<sub>3</sub>&quot;&quot; كل شهرين. في حال وجود خطورة مرتفعة لحدوث نقص، سيُقيَّم الطبيب ما إذا كنت بحاجة إلى زيادة الجرعة إلى عبوة واحدة بحجم جرعة واحدة بما يساوي 50,000 وحدة دولية من فيتامين &quot; د<sub>3</sub>&quot; مرة واحدة في الشهر.</p><p dir="RTL">للعلاج الجرعة الموصى بها هي عبوة واحدة بحجم جرعة واحدة (بما يساوي 50,000 وحدة دولية من فيتامين &quot; د<sub>3</sub>&quot; مرة واحدة في الأسبوع لمدة 8-6 أسابيع يتبعها علاج المداومة، والذي سيقيم من قبل طبيبك استنادا إلى حالتك الصحية.</p><p dir="RTL">إذا تناولت كمية أكثر مما يجب من ديبازا</p><p dir="RTL">في حال الابتلاع / التناول العرضي لجرعة زائدة من ديبازا، أبلغ الطبيب فورا أو قم بزيارة أقرب مستشفى.</p><p dir="RTL">في حال تناول جرعة زائدة، قد يكون هناك ارتفاع في مستويات الكالسيوم بالدم والبول، مصحوباً بالأعراض التالية: غثيان وقيء، وعطش، وعطش شديد. وزيادة كمية البول التبول المتكرر، وإمساك وجفاف.</p><p dir="RTL">يمكن أن تسبب الجرعة الزائدة المتكررة تراكم الأملاح الكالسيوم في الأوعية الدموية والأعضاء.</p><p dir="RTL">يمكن أن يؤدي استخدام جرعة زائدة من فيتامين &quot;د&quot; أثناء الأشهر الستة الأولى من الحمل إلى ضرر خطير بالجنين وحديث الولادة.</p><p dir="RTL">إذا أغفلت تناول ديبازا</p><p dir="RTL">لا تتناول جرعة مضاعفة لتعويض جرعة أغفلتها.</p><p dir="RTL">إذا توقفت عن تناول ديبازا</p><p dir="RTL">إذا كانت لديك أية أسئلة إضافية حول استخدام هذا الدواء، فاستشر طبيبك أو الصيدلي الخاص بك.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثله مثل كافة الأدوية، قد يسبب هذا الدواء آثارا جانبية، على الرغم من عدم حدوثها لدى الجميع.</p><p dir="RTL">مدرج أدناه الآثار الجانبية التي تم الإبلاغ عنها مع استخدام فيتامين &quot;د&quot;:</p><p dir="RTL">- تفاعلات حساسية</p><p dir="RTL">- ضعف فقدان الشهية عطش</p><p dir="RTL">- نعاس، ارتباك</p><p dir="RTL">- صداع</p><p dir="RTL">- إمساك، إطلاق غازات انتفاخ البطن بالغازات، ألم بالمعدة، غثيان، قيء إسهال، مذاق معدني جفاف الفم</p><p dir="RTL">- طفح جلدي، حكة</p><p dir="RTL">- تراكم مفرط للكالسيوم في الكلى كلاس كلوي زيادة كمية البول التبول المتكرر)، عطش شديد الشرب المتكرر مرض كلوي (قصور كلوي)</p><p dir="RTL">- ارتفاع مستويات الكالسيوم في الدم فرط كالسيوم الدم) وفي البول (فرط كالسيوم البول).</p><p dir="RTL"><strong>الإبلاغ عن الآثار الجانبية</strong></p><p dir="RTL">إذا ظهرت لديك أية آثار جانبية، فتحدث إلى الطبيب أو الصيدلي الخاص بك. يشمل ذلك أية آثار جانبية محتملة، غير المدرجة في هذه النشرة. بالإبلاغ عن الآثار الجانبية، يمكنك المساعدة في تقديم المزيد من المعلومات حول أمان هذا الدواء.</p><p>&nbsp;</p><p dir="RTL">- المركز الوطني للتيقظ الدوائي</p><p dir="RTL">- فاکس: +966-11-205-7662</p><p dir="RTL">- رقم الهاتف : 0966-11-2038222 وطلب أرقام التحويلات التالية</p><p dir="RTL">2317-2356-2340</p><p dir="RTL">- الرقم المجاني: 19999</p><p dir="RTL">- البريد الإلكتروني: npc.drug@sfda.gov.sa</p><p dir="RTL">- الموقع الإلكتروني : &nbsp;http://ade.sfda.gov.sa/</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يحفظ هذا الدواء بعيدًا عن رؤية ومتناول الأطفال.</p><p dir="RTL">لا تستخدم هذا الدواء بعد تاريخ انتهاء الصلاحية المدون على العبوة</p><p dir="RTL">الكرتونية بعد كلمة &quot;EXP&quot;. يُشير تاريخ انتهاء الصلاحية إلى اليوم الأخير من ذلك الشهر.</p><p dir="RTL">لا تتخلص من الأدوية عن طريق إلقائها في مياه الصرف أو مع المخلفات المنزلية. استشر الصيدلي الخاص بك حول كيفية التخلص من الأدوية التي لم تعد تستخدمها. سوف تساعد هذه الإجراءات في الحفاظ على البيئة.</p><p dir="RTL">يحفظ في درجة حرارة لا تتعدى 30 درجة مئوية. لا تعرضه للتجمد.</p><p dir="RTL">يحفظ الدواء في العبوة الأصلية لحمايته من الضوء.</p><p dir="RTL"><strong><u>ديبازا </u></strong><strong><u>10,000</u></strong><strong><u> &nbsp;وحدة دولية ملل قطرات عن طريق الفم، محلول</u></strong></p><p dir="RTL">تنتهي صلاحية هذا الدواء بعد 5 أشهر من فتح الزجاجة سجل تاريخ الفتح في القسم المخصص على العبوة الكرتونية.</p><p dir="RTL">بعد انقضاء هذه الفترة، يجب التخلص من بقايا الدواء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">ما هي محتويات ديبازا؟</p><p dir="RTL">ديبازا 10,000 وحدة دولية ملل قطرات عن طريق الفم، محلول</p><p dir="RTL">المادة الفعالة هي كوليكالسيفيرول (فيتامين &quot; د<sub>3</sub>&quot;) 2,5 مجم بما يعادل 10,000 وحدة دولية.</p><p dir="RTL">تحتوي القطرة الواحدة على 250 وحدة دولية من فيتامين &quot; د<sub>3</sub>&quot;.</p><p dir="RTL">المكون الآخر هو زيت الزيتون المنقى.</p><p dir="RTL">ديبازا 25.000 وحدة دولية / 2.5 ملل محلول عن طريق الفم</p><p dir="RTL">في عبوة واحدة تحتوي على جرعة واحدة</p><p dir="RTL">المادة الفعالة هي كوليكالسيفيرول (فيتامين &quot;د&quot;) &nbsp;0.625 مجم بما يعادل 25,000 وحدة دولية.</p><p dir="RTL">المكون الآخر هو زيت الزيتون المنقى.</p><p dir="RTL">ديبازا 50,000 وحدة دولية / 2,5 ملل محلول عن طريق الفم</p><p dir="RTL">في عبوة واحدة تحتوي على جرعة واحدة</p><p dir="RTL">المادة الفعالة هي كوليكالسيفيرول (فيتامين &quot; د<sub>3</sub>&quot;) 1,25 مجم بما يُعادل 50,000 وحدة دولية.</p><p dir="RTL">- المكون الآخر هو زيت الزيتون المنقى.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><u>قطرات عن طريق الفم، محلول</u></p><p dir="RTL">ديبازا معد في هيئة محلول في عبوة زجاجية كهرمانية اللون، مغلقة بغطاء من البولي بروبيلين المقاوم لعبث الأطفال.</p><p dir="RTL">يتوفر في عبوة بها زجاجة واحدة 10 ملل ، وقطارة واحدة.</p><p dir="RTL"><u>محلول عن طريق الفم</u>: ديبازا معد في هيئة محلول في عبوة كهرمانية اللون.</p><p dir="RTL">مغلقة بغطاء من البولي بروبيلين.</p><p dir="RTL">يتوفر في عبوات بها 1 ، 2 أو 4 عبوات تحتوي على جرعة واحدة، بكل منها 2,5 ملل</p><p dir="RTL">قد لا يتم تسويق جميع أحجام العبوات.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">ABIOGEN PHARMA S.p.A. - Via Meucci,</p><p dir="RTL">36 -Ospedaletto - Pisa, Italy</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            May 2022
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Dibasa 10,000 I.U/mL oral drops, solution Dibasa 25,000 I.U./2.5 mL oral solution Dibasa 50,000 I.U./2.5 mL oral solution
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Dibasa 10,000 I.U./mL oral drops, solution
10 mL contain: cholecalciferol (vitamin D3) 2.5 mg equivalent to 100,000 I.U.
1 drop contains: 250 I.U. of vitamin D3.

Dibasa 25,000 I.U./2.5 mL oral solution
One single-dose container contains cholecalciferol (vitamin D3) 0.625 mg equivalent to 25,000
I.U.

Dibasa 50,000 I.U./2.5 mL oral solution
One single-dose container contains cholecalciferol (vitamin D3) 1.25 mg equivalent to
50,000 I.U.

For the full list of excipients, see section 6.1


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                −	Oral solution
−	Oral drops, solution

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Prevention and treatment of vitamin D deficiency.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Dibasa can be administered o n a daily, weekly, monthly or annual basis (see section 5.2). In the case of oral therapy, it is recommended to take Dibasa with meals (see section 5.2). Intramuscular therapy is indicated only in case of malabsorption syndromes.</p><p><u>P</u><u>r</u><u>evention of vitamin D deficiency:</u> preventive administration of Dibasa is advised in all conditions characterised by &nbsp;greater risk of deficiency or &nbsp;increased need. It is generally acknowledged&nbsp; that prevention of vitamin D deficiency should be carried out:</p><p>&minus;&nbsp;&nbsp; in a systematic manner in newborns (particularly in preterm babies), in breastfed infants, in pregnant women (final trimester) and in breastfeeding women in late winter and spring, in &nbsp;the elderly and possibly in children and adolescents in the event of insufficient exposure to sunlight;</p><p>&minus;&nbsp;&nbsp;&nbsp; in the following conditions:</p><p>▪&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; minimal sun exposure or intense skin pigmentation, unbalanced diet (low in calcium, vegetarian, etc.), extensive dermatological disorders or granulomatous diseases (tuberculosis, leprosy, etc.);</p><p>▪&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; patients treated with anticonvulsants (barbiturates, phenytoin, primidone);</p><p>▪&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; patients receiving long-term corticosteroid therapy;</p><p>&nbsp;</p><p>▪&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; digestive disorders (intestinal malabsorption, mucoviscidosis or cystic fibrosis);</p><p>▪&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; liver insufficiency.</p><p>&nbsp;</p><p><u>T</u><u>r</u><u>eatment of vitamin D deficiency:</u> Vitamin D deficiency must be identified clinically and/or by laboratory tests (&lt;25 nmol/l). The treatment is designed to replenish vitamin D &nbsp;reserves &nbsp;and &nbsp;will &nbsp;be &nbsp;followed &nbsp;by&nbsp; maintenance &nbsp;therapy &nbsp;if &nbsp;the &nbsp;risk &nbsp;of &nbsp;deficiency persists (1400-2000 I.U./day). Follow-up 25(OH)D measurements should be made approximately three to four months after initiating maintenance therapy to confirm that the target level has been achieved). In the majority &nbsp;of &nbsp;cases, &nbsp;during &nbsp;the treatment phase, it is recommended not to exceed a cumulative dose of 600,000 I.U. per year, unless otherwise advised by a doctor.</p><p>As &nbsp;an &nbsp;indication, &nbsp;the &nbsp;following &nbsp;dosage &nbsp;scheme &nbsp;is &nbsp;provided, &nbsp;to &nbsp;be &nbsp;adapted &nbsp;as established by the &nbsp;doctor &nbsp;on &nbsp;the &nbsp;basis &nbsp;of &nbsp;nature &nbsp;and &nbsp;severity &nbsp;of &nbsp;the &nbsp;deficiency status (see also section 4.4).</p><p>&nbsp;</p><p><em><u>Di</u></em><em><u>basa 10,000 I.U./mL oral drops, solution</u></em></p><p>The daily doses listed below can be taken even on a weekly &nbsp;basis &nbsp;by multiplying the indicated daily dose by seven.</p><p><strong>N</strong><strong>e</strong><strong>w</strong><strong>bo</strong><strong>r</strong><strong>n</strong><strong>s, Children and Adolescents (&lt; 18 years of age)</strong></p><p><em>P</em><em>r</em><em>evention</em>: 2-4 drops per day (equivalent to 500-1,000 I.U. of vitamin D3)</p><p><em>T</em><em>r</em><em>eatment: </em>8-16 drops per day (equivalent to 2,000-4,000 I.U. of vitamin D3) for 4-5 months.</p><p><strong>P</strong><strong>r</strong><strong>egnant women</strong></p><p>2-3 drops per day (equivalent to 500-750 I.U. of vitamin D3) in the final trimester.</p><p><strong>A</strong><strong>d</strong><strong>u</strong><strong>lt</strong><strong>s and the Elderly</strong></p><p><em>P</em><em>r</em><em>evention: </em>3-4 drops per day (equivalent to 750-1,000 I.U. of vitamin D3). In patients at a high risk of deficiency, it may be necessary to increase the dose to up to 8 drops per day (equivalent to 2,000 I.U. of vitamin D3).</p><p><em>T</em><em>r</em><em>eatment:&nbsp;&nbsp;&nbsp; </em>20-30 drops per day (equivalent to 5,000-7,500 I.U. of vitamin D3) for 2 months, followed by the maintenance therapy (see above &ldquo;Treatment of vitamin D</p><p>deficiency&rdquo;).</p><p><em><u>I</u></em><em><u>nstructions for use</u></em></p><p>The package contains 1 bottle and a dropper. The bottle is equipped with a child proof cap. The dropper has its own case. To use, follow the instructions below:</p><p>a. &nbsp;open the bottle by removing the cap as follows: press and unscrew at the same time (see Figure 1);</p><p>b. &nbsp;unscrew the plastic case containing the tip of the dropper (see Figure 2);</p><p>c. &nbsp;insert the dropper into the bottle to extract the contents. Measure out the drops in a tablespoon and administer (see &ldquo;Posology and method of administration&rdquo;);</p><p>d. close the bottle (see Figure 3). Screw the cap on the tip of the dropper;</p><p>e. replace the bottle and the dropper in the package.</p><p><img src="data:image/png;base64,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" alt="" width="533" height="440" vspace="0" hspace="0" border="0" style="width:533px;height:440px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" /></p><p><em><u>Di</u></em><em><u>basa 25,000 I.U. /2.5 mL oral solution</u></em></p><p><strong>N</strong><strong>ewborns, Children and Adolescents (&lt; 18 years of age)</strong></p><p><em>P</em><em>r</em><em>evention</em>: &nbsp;1 single-dose container (equivalent to 25,000 I.U. of vitamin D3) every</p><p>1-2 months.</p><p><em>T</em><em>r</em><em>eatment</em>: 1 single dose container (equivalent to 25,000 I.U. of vitamin D3) once a week for 8-12 weeks, followed by the maintenance therapy (see above &ldquo;Treatment of vitamin D deficiency&rdquo;).</p><p><strong>A</strong><strong>d</strong><strong>u</strong><strong>lt</strong><strong>s and the Elderly</strong></p><p><em>P</em><em>r</em><em>evention</em>: 1 single dose container (equivalent to 25,000 I.U. of vitamin D3) once a month. In patients at a high risk of deficiency, it may be necessary to increase the dose &nbsp;to 2 single dose containers (equivalent &nbsp;to 50,000 I.U. of vitamin D3) once a month.</p><p><em>T</em><em>r</em><em>eatment</em>: 2 single dose containers (equivalent to 50,000 I.U. of vitamin D3) once a week for 6-8- weeks, followed by the maintenance therapy (see above &ldquo;Treatment of</p><p>vitamin D deficiency&rdquo;).</p><p>&nbsp;</p><p><em><u>Di</u></em><em><u>basa 50,000 I.U. /2.5 mL oral solution</u></em></p><p><strong>N</strong><strong>e</strong><strong>w</strong><strong>bo</strong><strong>r</strong><strong>n</strong><strong>s, Children and Adolescents (&lt; 18 years of age)</strong></p><p><em>P</em><em>r</em><em>evention</em>: 1 single-dose container (equivalent to 50,000 I.U. of vitamin D3) every</p><p>2-4 months.</p><p><em>T</em><em>r</em><em>eatment</em>: 1 single-dose container (equivalent to 50,000 I.U. of vitamin D3) once a week for 4-6 weeks, followed by the maintenance therapy (see above &ldquo;Treatment of vitamin D deficiency&rdquo;).</p><p><strong>A</strong><strong>d</strong><strong>u</strong><strong>lt</strong><strong>s and the Elderly</strong></p><p><em>P</em><em>r</em><em>evention</em>: 1 single-dose container (equivalent to 50,000 I.U. of vitamin D3) every 2 months. In patients at a high risk of deficiency, it may be necessary to increase the dose to 1 single-dose container (equivalent to 50,000 I.U. of vitamin D3) once a</p><p>month.</p><p><em>T</em><em>r</em><em>eatment</em>: 1 single-dose container (equivalent to 50,000 I.U. of vitamin D3) once a week for 6-8 weeks, followed by the maintenance therapy (see above &ldquo;Treatment of vitamin D deficiency&rdquo;).</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to cholecalciferol or to any of the excipients listed in section 6.1. Hypercalcaemia, hypercalciuria.
Kidney stones (nephrolithiasis, nephrocalcinosis).
Renal insufficiency (see section 4.4).

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In the event of prolonged administrations at high doses, it is recommended to monitor the serum level of 25-hydroxy-cholecalciferol. Stop taking Dibasa when the serum level of 25-hydroxy-cholecalciferol exceeds 100 ng/mL (equal to 250 nmol/L).</p><p>&nbsp;</p><p>In elderly patients already undergoing treatment with cardiac glycosides or diuretics, it is important to monitor calcaemia and calciuria. In the event of hypercalcaemia or renal insufficiency, reduce the dose or discontinue treatment.</p><p>To avoid overdose, take into account the total dose of vitamin D in the event of</p><p>association with treatments already containing vitamin D, foods enriched with vitamin</p><p>D, or if using milk enriched with vitamin D.</p><p>&nbsp;</p><p>In the following cases, it may be necessary to increase the indicated doses:</p><p>&bull;&nbsp;&nbsp; &nbsp;Patients undergoing treatment with anticonvulsants or barbiturates (see section</p><p>4.5);</p><p>&bull;&nbsp;&nbsp; &nbsp;Patients undergoing treatment with corticosteroid therapy (see section 4.5);</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp; Patients undergoing treatment with lipid-lowering agents such as colestipol, cholestyramine and orlistat (see section 4.5);</p><p>&bull;&nbsp;&nbsp; &nbsp;Patients undergoing treatment with antacids containing aluminium (see section</p><p>4.5);</p><p>&bull;&nbsp;&nbsp; &nbsp;Obese patients (see section 5.2);</p><p>&bull;&nbsp;&nbsp; &nbsp;Digestive disorders (intestinal malabsorption, mucoviscidosis or cystic fibrosis);</p><p>&bull;&nbsp;&nbsp; &nbsp;Liver insufficiency.</p><p>The product should be prescribed with caution to patients with sarcoidosis, due to a possible increase in the metabolism of vitamin D in its active form. It is necessary to monitor serum and urine calcium levels in these patients.</p><p>Patients with renal insufficiency have an altered metabolism of vitamin D, therefore, if they have to be treated with cholecalciferol, the effects on calcium and phosphate homeostasis should be monitored.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Concomitant use of anticonvulsants or barbiturates may reduce the effect of vitamin</p><p>D3 by metabolic inactivation.</p><p>In the case of treatment with thiazide diuretics, which decrease urinary elimination of calcium, monitoring of serum calcium levels is recommended.</p><p>Concomitant use of glucocorticosteroids may reduce the effect of vitamin D3.</p><p>In the event of treatment with drugs containing digitalis, oral administration of calcium combined with &nbsp;vitamin D &nbsp;increases the &nbsp;risk &nbsp;of digitalis toxicity (arrhythmia).&nbsp; &nbsp;Strict medical supervision is therefore required and, if necessary ECG monitoring and monitoring of serum calcium levels.</p><p>Concomitant &nbsp;use of aluminium-containing antacids may interfere with the efficacy of the &nbsp;medicinal &nbsp;product, &nbsp;reducing &nbsp;the &nbsp;absorption &nbsp;of &nbsp;vitamin &nbsp;D, &nbsp;while &nbsp;preparations containing magnesium may lead to a risk of hypermagnesaemia.</p><p>Studies on animals have suggested possible strengthening of the action of warfarin when administered with calciferol. Although there is no similar evidence with the use of &nbsp;cholecalciferol, it &nbsp;is &nbsp;best &nbsp;to &nbsp;exercise caution when &nbsp;both &nbsp;medicinal products are used concomitantly.</p><p>Cholestyramine, colestipol and orlistat reduce the absorption of vitamin D, while chronic alcoholism decreases Vitamin D reserves in the liver.</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>P</u><u>r</u><u>egnancy</u></p><p>In the first 6 months of pregnancy, vitamin D should be taken with caution due to the risk of teratogenic effects (see section 4.9).</p><p><u>Lac</u><u>t</u><u>ation</u></p><p>If necessary Vitamin D can be prescribed while a patient &nbsp;is breastfeeding. This supplementation does not replace the administration of vitamin D in the newborn.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There is no data&nbsp; available on the effects of this product on the ability to drive. However, an effect on this ability is unlikely.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>When the posology complies with actual individual requirements, Dibasa is well tolerated, also thanks to the body&rsquo;s ability to store cholecalciferol in adipose and muscular tissues (see section 5.2).</p><p>&nbsp;</p><p>The undesirable effects reported with the use of vitamin D are as follows: <em>Immune system disorders:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>hypersensitivity reactions <em>Metabolism and nutrition disorders:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>weakness, anorexia, thirst <em>Psychiatric disorders:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>drowsiness, confused state <em>Nervous system disorders:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>headaches</p><p><em>G</em><em>astrointestinal disorders:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</em>constipation, flatulence, abdominal pain, nausea, vomiting, diarrhoea, metallic taste, dry mouth</p><p>&nbsp;</p><p><em>S</em><em>kin and subcutaneous tissue disorders:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>rash, pruritus</p><p>&nbsp;</p><p><em>R</em><em>enal and urinary disorders:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>nephrocalcinosis, polyuria, polydipsia, renal insufficiency</p><p>&nbsp;</p><p><em>I</em><em>nvestigations:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>hypercalciuria, hypercalcaemia.</p><p>&nbsp;</p><p>&nbsp;</p><p><em><u>R</u></em><em><u>eporting of suspected adverse reactions</u></em></p><p>Reporting suspected adverse reactions after authorization of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions.</p><p>&nbsp;</p><p>&nbsp;</p><p>To report any side effect(s):</p><p>&bull; <strong>Saudi Arabia:</strong></p><p>&nbsp;</p><p>&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp; The National Pharmacovigilance Center (NPC)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; Fax: + (966-11) 2057662</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; Call NPC at: + (966-11) 2038222, Exts: 2317-2356-2340.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; SFDA Call Center: 19999</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; Website: &nbsp;https://ade.sfda.gov.sa/</p><p>&nbsp;</p><p>&nbsp;</p><p><!--[if gte vml 1]><v:shapetype id="_x0000_t75" coordsize="21600,21600"
 o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe" filled="f"
 stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="_x0000_s1028" type="#_x0000_t75" style='position:absolute;
 left:0;text-align:left;margin-left:115.1pt;margin-top:.45pt;width:17.3pt;
 height:12.25pt;z-index:-251657728;mso-position-horizontal-relative:page'>
 <v:imagedata src="file:///C:/Users/ralnahdi/AppData/Local/Temp/msohtmlclip1/01/clip_image002.png"
  o:title=""/>
 <w:wrap anchorx="page"/>
</v:shape><![endif]--><img width="23" height="16" src="file:///C:/Users/ralnahdi/AppData/Local/Temp/msohtmlclip1/01/clip_image003.gif" /><strong>Ot</strong><strong>her GCC States:</strong></p><p>&nbsp;</p><p>Please contact the relevant competent authority.</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Discontinue Dibasa when calcaemia exceeds 10.6 mg/dL (2.65 mmol/L) or if calciuria exceeds 300 mg/24 hours in adults or 4-6 mg/kg/day in children. &nbsp;An overdose &nbsp;is revealed &nbsp;as &nbsp;hypercalciuria &nbsp;and &nbsp;hypercalcaemia, &nbsp;the &nbsp;symptoms &nbsp;of &nbsp;which &nbsp;are &nbsp;as follows: nausea, vomiting, thirst, polydipsia, polyuria, constipation and dehydration. Chronic overdoses may lead to vascular and organ calcification as a result of hypercalcaemia. An overdose during the first 6 months of pregnancy may have toxic effects on the foetus: there is a correlation between excess intake or extreme maternal sensitivity to vitamin D during pregnancy and the delayed mental and physical development of the child, supravalvular aortic stenosis and retinopathy. Maternal hypercalcaemia can also lead to the suppression of parathyroid function in infants resulting in hypocalcaemia, tetany and convulsions.</p><p><u>T</u><u>r</u><u>eatment in the event of overdose</u></p><p>Discontinue the administration of Dibasa and proceed with rehydration.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Vitamin D and analogues, cholecalciferol. ATC code: A11CC05</p><p>Vitamin D corrects vitamin D deficiency and increases the intestinal absorption of</p><p>calcium.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>As &nbsp;with &nbsp;other &nbsp;lipid-soluble &nbsp;vitamins, &nbsp;cholecalciferol &nbsp;absorption &nbsp;in &nbsp;the &nbsp;intestine &nbsp;is assisted by a concomitant intake of foods containing fats.</p><p>Cholecalciferol is present in the bloodstream in association with specific &alpha;-globulins which transport it to the liver, where it is hydroxylated into 25-hydroxycholecalciferol. A second hydroxylation occurs in the kidneys, where 25-hydroxycholecalciferol is transformed into 1,25-dihydroxy-cholecalciferol which is the active metabolite of vitamin D responsible for the effects on phosphocalcium metabolism.</p><p>Non-metabolised &nbsp;cholecalciferol accumulates in adipose and muscular tissues to be</p><p>made available according to the body&rsquo;s needs: for this reason Dibasa can also be administered on a weekly, monthly or annual basis. In obese patients, the bioavailability of vitamin D is reduced due to the excess adipose tissue.</p><p>Vitamin D is eliminated through the faeces and urine.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Preclinical &nbsp;studies &nbsp;carried &nbsp;out &nbsp;on &nbsp;various &nbsp;animal &nbsp;species &nbsp;have &nbsp;demonstrated &nbsp;that toxic effects occur in &nbsp;animals at doses much higher than those required for therapeutic use in humans.</p><p>In repeat-dose toxicity studies, the effects most commonly found were: increased calciuria, decreased phosphaturia and proteinuria</p><p>Hypercalcaemia&nbsp; was &nbsp;reported &nbsp;at &nbsp;high &nbsp;doses. &nbsp;In &nbsp;a &nbsp;state &nbsp;of &nbsp;prolonged hypercalcaemia the &nbsp;most &nbsp;frequent histological alterations (calcification) have &nbsp;involved</p><p>&nbsp;</p><p>the kidneys, heart, aorta, testicles, thymus and intestinal mucosa.</p><p>Reproductive toxicity studies have shown that cholecalciferol does not have negative effects on fertility and reproduction.</p><p>At &nbsp;doses&nbsp;&nbsp;&nbsp;&nbsp; equivalent &nbsp;to &nbsp;the &nbsp;therapeutic &nbsp;doses, &nbsp;cholecalciferol &nbsp;has &nbsp;no &nbsp;teratogenic activity.</p><p>Cholecalciferol has no potential mutagenic and carcinogenic activity.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Di</em><em>basa 10,000 I.U./mL oral drops, solution</em>: refined olive oil. <em>Dibasa 25,000 I.U./2.5 mL oral solution: </em>refined olive oil. <em>Dibasa 50,000 I.U./2,5 mL oral solution </em>refined olive oil.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There are no known incompatibilities with other medicinal products.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Dibasa 10,000 I.U./mL oral drops, solution: 2 years  in intact packaging. After first opening of the bottle: 5 months.
Dibasa 25,000 I.U. /2.5 mL oral solution: 2 years.
Dibasa 50,000 I.U. /2.5 mL oral solution: 2 years

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30&deg; C. Do not freeze.</p><p>Store in the original package in order to protect from light.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em><u>Di</u></em><em><u>basa 10,000 I.U./mL oral drops, solution</u></em></p><p>Amber glass bottle containing 10 mL, closed with a polypropylene child-proof cap. The package contains 1 bottle and 1 dropper.</p><p><em><u>Di</u></em><em><u>basa 25,000 I.U. /2.5 mL oral solution</u></em></p><p>Amber glass container containing 2.5 mL, closed with a polypropylene cap. Packs of 1,</p><p>2 or 4 single-dose containers.</p><p><em><u>Di</u></em><em><u>basa 50,000 I.U. /2.5 mL oral solution</u></em></p><p>Amber glass container containing 2.5 mL, closed with a polypropylene cap. Packs of 1,</p><p>2 or 4 single-dose containers.</p><p>&nbsp;</p><p>&nbsp;</p><p>Not all pack sizes may be marketed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                ABIOGEN PHARMA S.p.A. Via Meucci 36
Ospedaletto – Pisa
ITALY

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                May 2022
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>